CPSI
Clear direction for healthcare information solutions
2 0 0 3 A N N U A L R E P O R T
Financial Highlights
(in thousands, except per share data)
Years Ended
December 31,
2003
$ 81,303
48,404
32,899
2002
$ 73,744
42,925
30,819
20,353
18,750
12,546
216
121
12,883
5,017
$ 7,866
$
$
0.75
0.75
12,069
190
362
12,621
1,971
$ 10,650
$
$
1.06
1.06
$ 12,621
4,577
$ 8,044
0.80
$
0.80
$
10,488
10,537
10,024
10,061
Total revenues
Cost of sales
Gross profit
Operating expenses
Operating income
Interest income, net
Other
Income before taxes
Provision for income taxes
Net income
Basic earnings per share
Diluted earnings per share
Pro Forma Income Data (1)
Income before taxes as reported
Pro forma provision for income taxes
Pro forma net income
Pro forma basic earnings per share
Pro forma diluted earnings per share
Weighted average shares outstanding:
Basic
Diluted
(1) Pro forma adjustments reflect the provision for income taxes as if the Company had been taxed as a C corporation for all
periods presented.
Revenues
0
5
1
,
2
3
$
0
3
5
,
0
5
$
2
2
2
,
9
4
$
6
6
6
,
9
5
$
4
4
7
,
3
7
$
3
0
3
,
1
8
$
Net Income (2)
7
2
3
,
3
$
3
1
6
,
5
$
5
6
0
,
3
$
9
4
4
,
5
$
4
4
0
,
8
$
6
6
8
,
7
$
Hospital Clients
5
8
2
7
2
3
2
6
3
0
0
4
4
4
4
0
9
4
1 0 0 , 0 0 0
8 0 , 0 0 0
6 0 , 0 0 0
4 0 , 0 0 0
2 0 , 0 0 0
1 0 , 0 0 0
8 , 0 0 0
6 , 0 0 0
4 , 0 0 0
2 , 0 0 0
5 0 0
4 0 0
3 0 0
2 0 0
1 0 0
98 99 00 01 02 03
98 99 00 01 02 03
98 99 00 01 02 03
(2) Net income for years 1998 through 2002 are pro forma for comparative purposes.
C P S I
2 0 0 3 A N N U A L R E P O R T
1
D A V I D A . D Y E
President and Chief Executive Officer
Dear Stockholders:
CPSI is much more than a hospital
software company. CPSI is in the business
information technology
of providing
products and services to community
hospitals, thereby enabling them to
effectively and efficiently manage their
financial and clinical operations so that
they can focus on their primary business
objective, quality patient care.
A Unique Approach –
the Single Source Solution
There are several companies that strive to
provide such a solution. However, CPSI
is unique in the hospital information
technology industry because of our ability
to provide our hospital clients with a
single source solution for all of their
information technology requirements. We
provide
in-house
integrated, 100%
developed software for every functional
area of a hospital and for the entities that
our hospitals often operate, such as
nursing homes, home health agencies, and
physician clinics. We sell and support all
of the hardware necessary to be used in
conjunction with our software. From our
in Mobile, we print patient
offices
statements, send electronic insurance
claims, and even manage entire business
office operations
for some of our
customers. CPSI is the only information
service company that provides all these
services; our competition does not.
In 2003, we
further distinguished
ourselves from the other companies in our
field by enhancing and continuing to
develop our single source solution. For
example, in the fourth quarter, CPSI
added an extremely significant software
2
C P S I
2 0 0 3 A N N U A L R E P O R T
including
radiologists,
application to our product suite, a Picture
Archiving and Communications System
(PACS). This module allows all of the
many physicians involved in a patient’s
care,
family
physicians, consultative physicians, and
surgeons, to have real time access to
diagnostic quality digital radiology images,
such as MRI, CT, and ultrasound. Why is
this so important to our company?
Because the complete CPSI system now
enables a hospital to have not only a
paperless patient chart through the use of
our clinical applications such as lab,
pharmacy, and nursing point-of-care, but
also a filmless chart, or in other words, a
record all
fully electronic medical
contained within the CPSI system. Unlike
all of the other major hospital information
system vendors, CPSI elected to develop
our PACS in-house rather than acquiring
or partnering with a third-party vendor.
CPSI and our hospital clients will benefit
from this decision for years to come.
Our approach to building and servicing
our products and services internally has
served us well for almost 25 years. The
hospitals that choose CPSI as their hospital
information system partner appreciate the
value of dealing with a single source
vendor for all of their information system
requirements. Their goals are consistent:
> provide clinicians with real time access
to clinical information from anywhere at
anytime,
> facilitate the seamless movement of
the
patient
financial and clinical departments,
resulting in the elimination of lost
information between
charges and the improvement of back
office efficiency,
> do away with the need for cumbersome
and costly interfaces between disparate
systems, and
> have one phone number to call for any
and all of their information technology
questions and problems.
2003 – Challenging Yet Prosperous
reasons,
of
as nurses
2003 was a notably difficult year
financially for community hospitals for
several
including a weak
Medicare and Medicaid reimbursement
environment, high salary costs due to a
clinical
shortage
nationwide
and
such
professionals
pharmacists, and lower than anticipated
patient admissions. The difficult year for
our target market led to a challenging year
for CPSI. Many hospitals delayed making
significant
technology
information
purchases due to lack of available capital.
Although our company added a record 48
new hospital clients in 2003, most of these
hospitals approved purchases for the
minimum amount of software needed to
begin the installation of an integrated
system and postponed expenditures for
additional products that we believe they
might have otherwise purchased to meet
their operational and competitive needs.
We are pleased to report that, despite this
tough environment, CPSI had another
successful year financially. Our gross
revenue increased 10% over 2002, while
our bottom line remained constant. Cash
flow from operations and total cash
collections reached record highs, eclipsing
net income and gross revenues, respectively,
We continue to believe that our strong cash
performance highlights both the quality of our
customer service and our conservative revenue
recognition practices.
“
”
for the year, which we feel is a remarkable
accomplishment. We continue to believe
that our strong cash performance highlights
both the quality of our customer service
and our conservative revenue recognition
practices. CPSI’s revenue growth rate for
the last five and 10 years ending 2003 is
20%. We firmly believe that our company
is positioned to experience similar growth
going forward.
Looking to the Long Term
created
As a result of
the new Medicare
Prescription Drug Bill, community hospitals
looking forward to substantially
are
improved Medicare
reimbursement
beginning in 2004. In the past, Medicare’s
payment
a
formula has
disproportionate burden on smaller,
community-based hospitals, which also
typically depend on Medicare for a greater
share of their payer mix than larger, urban
facilities. The new Medicare bill, however,
rectifies some of this imbalance, raising
Medicare reimbursements to rural hospitals
by an estimated $25 billion over the next
ten years.
Meanwhile,
the underutilization of
information technology within healthcare
remains staggering. For example, in our
target market of hospitals with under 300
beds, less than 20% have a point-of-care
nursing documentation system and fewer
than 5% have bedside medication
verification, PACS, and computerized
physician order entry systems. This
means that more than 95% of the
community hospitals in this country still
maintain a predominantly paper chart as
opposed to an electronic medical record.
C P S I
2 0 0 3 A N N U A L R E P O R T
3
We believe that we are in the right place, at the right
time, and that we have the right expertise and
approach to be the leader in our market.
“
”
At some point in the near future, it will
become necessary for hospitals of all sizes
to be fully automated across the continuum
of care in order to remain competitive.
Clinicians and patients will demand access
to their medical information electronically,
and as HIPAA enforcement becomes more
of a priority, the security and record
keeping necessary for compliance will
force hospitals to automate and to do so
with integration in mind.
the growing need
In addition,
for
information technology in the healthcare
industry is gaining national political and
media attention. The focus is primarily on
the use of technology to improve patient
safety and therefore reduce the cost of
healthcare delivery. CPSI’s application
software is being used around the country
by our customers to enhance quality
patient care. For example, many of our
clients utilize handheld devices with built
in barcode scanners to verify at the patient
bedside that the patient is receiving the
correct medication at the right dose and at
the right time, greatly reducing the
possibility of a medication error. Several
of our hospital customers have installed
our ChartLink™ product, which gives
physicians real time access to the patient’s
chart to review such critical information as
vital signs, lab results, and radiology
reports. After reviewing this information,
doctors are able to enter and sign
orders
medication
electronically
CPSI
using
Computerized Physician Order Entry
application. This software checks for
adverse drug-to-drug and drug-to-allergy
interactions and eliminates the difficulty in
ancillary
the
and
4
C P S I
2 0 0 3 A N N U A L R E P O R T
interpreting hand written orders, both of
which are proven patient safety benefits.
We believe that as the financial climate
among community hospitals improves and
as the demand for information technology
within the healthcare industry continues
to steadily increase, CPSI will remain in an
ideal position to capitalize from the
combined forces of these trends. Our plan
is to continue to lead the community
hospital marketplace through the addition
of new client hospitals to our system and
to continue to grow our recurring revenue
stream through the addition of statement,
electronic billing, and business office
outsourcing services with our existing
customers.
We believe that we are in the right place, at
the right time, and that we have the right
expertise and approach to be the leader in
our market. This combination, we are
convinced, makes CPSI the partner of
choice for community hospitals and
positions our company to deliver increasing
value to you, our shareholders. We
appreciate your commitment and support.
Sincerely,
David A. Dye
President and Chief Executive Officer
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________
FORM 10-K
FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO
SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934 for the fiscal year ended December 31, 2003, or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934 for the transition period from to .
Commission file number: 000-49796
COMPUTER PROGRAMS AND SYSTEMS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction
of Incorporation or Organization)
6600 Wall Street, Mobile, Alabama
(Address of Principal Executive Offices)
74-3032373
(I.R.S. Employer
Identification No.)
36695
(Zip Code)
(251) 639-8100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Securities registered pursuant to Section 12(g) of the Act:
None
Common Stock, $.001 par value
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not
contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K
Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).
Yes
No
The aggregate market value of common stock held by non-affiliates of the registrant at June 30, 2003 was
$124,242,050.
As of March 10, 2004 the registrant had outstanding 10,489,849 shares of its common stock.
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of the definitive Proxy Statement for the Annual Meeting of Computer Programs and Systems, Inc.’s
stockholders to be held on May 13, 2004 are incorporated by reference into Part III of this report.
TABLE OF CONTENTS
Item No.
Page No.
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS .............................................. 1
PART I
1.
2.
3.
4.
PART II
Business ............................................................................................................................. 2
Overview................................................................................................................ 2
Industry Dynamics................................................................................................. 2
Our Solution........................................................................................................... 4
Strategy .................................................................................................................. 4
Our Products and Services ..................................................................................... 6
System Implementation and Training.................................................................. 14
Technology .......................................................................................................... 15
Research and Development ................................................................................. 15
Customers, Sales and Marketing ......................................................................... 16
Competition ......................................................................................................... 17
Internal Management Controls ............................................................................ 17
Intellectual Property............................................................................................. 18
Employees............................................................................................................ 18
Executive Officers .............................................................................................. 19
Company Website................................................................................................ 20
Properties ......................................................................................................................... 20
Legal Proceedings............................................................................................................ 20
Submission of Matters to a Vote of Security Holders ..................................................... 20
5.
6.
7.
7A.
8.
9.
9A.
Market for Registrant's Common Equity and Related
Stockholder Matters ........................................................................................................ 21
Selected Financial Data ................................................................................................... 22
Management's Discussion and Analysis of Financial
Condition and Results of Operations .............................................................................. 23
Quantitative and Qualitative Disclosures about
Market Risk..................................................................................................................... 39
Financial Statements and Supplementary Data............................................................... 39
Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure ............................................................................. 56
Controls and Procedures ................................................................................................... 56
PART III
10.
11.
12.
13.
14.
Directors and Executive Officers of the Registrant ........................................................ 57*
Executive Compensation ................................................................................................ 57*
Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters .................................................................................... 57*
Certain Relationships and Related Transactions............................................................. 58*
Principal Accountant Fees and Services ......................................................................... 58*
PART IV
15.
Exhibits, Financial Statement Schedules and Reports on Form 8-K ............................... 59
SIGNATURES.......................................................................................................................................... 60
* Portions of the definitive Proxy Statement for the Annual Meeting of our stockholders to be held on
May 13, 2004 are incorporated by reference in Part III of this Form 10-K.
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of
the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-
looking statements can be identified generally by the use of forward-looking terminology and words such
as "expects," "anticipates," "estimates," "believes," "predicts," "intends," "plans," "potential," "may,"
"continue," "should," "will" and words of comparable meaning. Without limiting the generality of the
preceding statement, all statements in this Annual Report relating to estimated and projected earnings,
margins, costs, expenditures, cash flows, growth rates and future financial results are forward-looking
statements. We caution investors that any such forward-looking statements are only predictions and are
not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual
results to differ materially from those projected in the forward-looking statements. Such factors may
include:
•
•
•
• overall business and economic conditions affecting the healthcare industry;
•
•
saturation of our target market and hospital consolidations;
changes in customer purchasing priorities and demand for information technology
systems;
competition with companies that have greater financial, technical and marketing
resources than we have;
failure to develop new technology and products in response to market demands;
fluctuations in quarterly financial performance due to, among other factors, timing of
customer installations;
failure of our products to function properly resulting in claims for medical losses;
•
• government regulation of our products and customers; and
•
interruptions in our power supply and/or telecommunications capabilities.
For more information about the risks described above and other risks affecting us, see “Risk
Factors” beginning on page 35 of this Annual Report. We also caution investors that the forward-looking
information described herein represents our outlook only as of this date, and we undertake no obligation
to update or revise any forward-looking statements to reflect events or developments after the date of this
Annual Report.
PART I
ITEM 1.
BUSINESS
Overview
We are a healthcare information technology company that designs, develops, markets, installs and
supports computerized information technology systems to meet the unique demands of small and midsize
hospitals. Our target market includes acute care community hospitals with 300 or fewer beds and small
specialty hospitals. We are a single-source vendor providing comprehensive software and hardware
products, complemented by data conversion, complete installation and extensive support. Our fully
integrated, enterprise-wide system automates the management of clinical and financial data across the
primary functional areas of a hospital. In addition, we provide services that enable our customers to
outsource certain data-related business processes which we can perform more efficiently. We believe our
products and services enhance hospital performance in the critical areas of clinical care, revenue cycle
management, cost control and regulatory compliance. From our initial hospital installation in 1981, we
have grown to serve more than 490 hospital customers across 45 states and the District of Columbia. In
2003, we generated revenues of $81.3 million from the sale of our products and services.
Industry Dynamics
The healthcare industry is the largest industry in the United States economy. The Centers for
Medicare and Medicaid Services, or "CMS," has calculated that fiscal 2003 total healthcare expenditures
in the United States were approximately $1.7 trillion, or approximately 15.3% of the U.S. gross domestic
product. CMS estimates that by fiscal 2013 total U.S. healthcare spending will reach $3.4 trillion, or
18.4% of the estimated U.S. gross domestic product.
Hospital services represents one of the largest categories of total healthcare expenditures.
According to CMS, in fiscal 2003 spending on hospital services amounted to $518.1 billion, or 30.9% of
total healthcare expenditures. According to the American Hospital Association, there are approximately
4,900 community hospitals in the United States, with approximately 4,100 in our target market of
hospitals with 300 or fewer acute care beds. In addition, there is a market of small specialty hospitals that
focus on discrete medical areas such as surgery, rehabilitation and psychiatry.
Notwithstanding the size and importance of the healthcare industry within the United States
economy, the industry is constantly challenged by changing economic dynamics, increased regulation and
pressure to improve the quality of healthcare. These challenges are particularly significant for the
hospitals in our target market due to their more limited financial and human resources. However, we
believe healthcare providers can successfully address these issues with the help of advanced medical
information systems. Specific examples of the challenges facing healthcare providers include the
following.
Changing Economic Dynamics. The federal Balanced Budget Act of 1997, or "BBA,"
significantly lowered Medicare reimbursements for hospital services. These reductions were projected to
total over $250 billion over five years. While the Budget Refinement Act of 1999 and the Benefits
Improvement Act of 2000 lessened the impact of the BBA, aggregate federal reimbursement for hospital
services is still significantly below pre-1997 levels. Additionally, the Medicaid program, which is a
federal/state program managed by the individual states and dependent in part on funding from the states,
is in crisis due to the increasing cost of healthcare and the detrimental effect of the lagging economy on
state revenues. As a result of the recent enactment of the Medicare Prescription Drug, Improvement and
Modernization Act of 2003, however, community hospitals are looking forward to substantially improved
2
Medicare reimbursement beginning in 2004. This new legislation is expected to raise Medicare
reimbursements to rural hospitals by an estimated $25 billion over the next ten years.
Health Insurance Portability and Accountability Act. The federal Health Insurance Portability
and Accountability Act of 1996, or "HIPAA," requires the implementation of national guidelines for
information management by healthcare organizations. Among other things, HIPAA mandates uniform
electronic transactions and code sets, improved data security and increased patient privacy. Final
regulations for privacy standards became effective in April 2003. Final regulations for electronic
transaction/code set standards were adopted in February 2002 and were to be effective in October 2003.
CMS, however, is currently allowing providers and payers to continue utilizing non-compliant transaction
code sets. The length of this grace period has not yet been determined. The final rules for security
standards were published in February 2003, and covered entities have until April 2005 to comply with the
new security standards.
HIPAA continues to be a major influence as illustrated by the results of the 15th Annual HIMSS
Leadership Survey sponsored by Superior Consultant Company. Survey respondents consider HIPAA
compliance more than any other matter as a top business issue that will affect healthcare in the next two
years. Approximately 48% of respondents identified upgrading information technology systems to meet
HIPAA requirements as the number one information technology priority for their organizations.
Approximately 47% of respondents identified increased patient safety as their number one priority. In
addition, results of the Winter 2004 Healthcare Industry HIPAA Compliance Survey conducted by
HIMSS and Phoenix Health Systems indicate that HIPAA readiness is still a serious concern. While
respondent hospitals are decreasing their HIPAA compliance budgets for 2004, the respondent hospitals
are still budgeting significant dollars to address HIPAA concerns. Vendors that offer information
solutions utilizing a common architecture and database structure, such as CPSI, are well positioned to
provide healthcare participants with effective solutions to the HIPAA requirements.
Activism for Improved Clinical Care. In November 1999, the Institute of Medicine published a
report entitled "To Err is Human: Building a Safer Healthcare System." The report indicated that
avoidable medical error is one of the top ten leading causes of death in the United States. The report also
estimates that medical error may add as much as $14.5 billion of preventable cost to the healthcare
industry. As a result of this study, automated medical information systems have been increasingly
identified as a key to improving patient care and reducing medical errors. For example, the Leapfrog
Group, a consortium of more than 100 public and private organizations including General Motors,
General Electric, AT&T and IBM, recommends that its members utilize hospitals with certain automated
medical information systems that are designed to limit medical errors. Moreover, California has adopted
legislation requiring hospitals to use automated medical information systems. We believe hospitals
utilizing fully integrated enterprise-wide medical information systems that allow professionals real-time
access to information such as electronic charts, treatment protocols and pathways, pharmaceutical records
and treatment schedules will be favored by large employers and government payers.
While economic, regulatory and consumer pressures such as those described above have
increased rapidly over the last several years, we believe healthcare organizations have historically
underinvested in information technology and services compared to other industries. This underinvestment
has caused healthcare providers to rely on non-integrated, complex and inefficient information systems. A
hospital's failure to adequately invest in modern medical information systems could result in fewer patient
referrals, cost inefficiencies, lower than expected reimbursement, increased malpractice risk and possible
regulatory infractions.
In the face of decreasing revenue and increasing pressure to improve patient care, healthcare
providers are in need of management tools that (1) increase efficiency in the delivery of healthcare
3
services, (2) reduce medical errors, (3) effectively track the cost of delivering services so those costs can
be properly managed and (4) increase the speed and rate of reimbursement. We believe the industry has
begun to embrace information technology as a management tool, evidenced by the fact that approximately
50% of the respondents to the 15th Annual HIMSS Leadership Survey referenced above predicted an
increase in their organizations' information technology operating budgets during the next twelve months.
We believe these dynamics will allow for future revenue growth.
Our Solution
We have tailored an information technology solution that effectively addresses the specific needs
of small and midsize hospitals. Due to their smaller operating budgets, community hospitals have limited
financial and human resources to operate manual or inefficient information systems. However, these
hospitals are expected to achieve the same quality of care and regulatory compliance as larger hospitals,
placing them in a particularly difficult operating environment.
We believe that the CPSI solution meets this challenge. We provide fully integrated, enterprise-
wide, HIPPA compliant medical information systems and services that collect, process, retain and report
data in the primary functional areas of a hospital, from patient care to clinical processing to administration
and accounting. As a key element of our complete solution, we provide ongoing customer service through
regular interaction with customers, customer user groups and extensive customer support. Further, we
offer outsourcing services that allow customers to avoid some of the fixed costs of a business office. We
are capable of providing a single-source solution for small and midsize hospitals, making us a partner in
their initiatives to improve operations and medical care.
Our customers continuously communicate with us through our support teams and through
organized user groups, allowing us to continue to provide a state-of-the-art solution that meets their
specific needs. By remaining sensitive and responsive to the ever-changing demands of our customers and
regularly updating our products, we believe we provide an information technology solution that meets the
needs of community hospitals. Our business has continued to grow because we have successfully
addressed the needs of community hospitals for fully integrated enterprise-wide information systems that
allow them to improve operating effectiveness, reduce costs and improve the quality of patient care.
Strategy
Our objective is to continue to grow as a leading provider of healthcare information technology
systems and services to small and midsize hospitals by following the same strategy that we have
successfully pursued for over twenty-four years, the key elements of which are described below.
Deliver a Single-Source Solution. When a customer purchases the CPSI system, we provide
everything necessary for the customer to implement and use our system. We deliver the application
software, computer hardware, peripherals, forms and supplies used in the comprehensive information
network. Our installation teams work extensively with each customer to convert existing data to the new
system, to install all of the necessary equipment and to train hospital personnel to use our system. After
installation, our support teams answer and address customer questions and issues related to any aspect of
the system. We also offer customers additional services such as business office outsourcing, electronic
billing outsourcing and ISP services. We believe our single-source approach to delivering a complete
information system makes our system easier and more convenient for customers to understand and
manage, which results in greater customer satisfaction and retention.
Provide Enterprise-Wide, Fully Integrated Software Applications. We have developed all of our
software products internally as part of our fully integrated system architecture. Our experience has taught
4
us that using a fully integrated system in the primary functional areas of a hospital ensures compatibility
among applications and avoids pitfalls associated with interfacing disparate systems. Our system utilizes
one central database where information is stored and used by all of our software applications. With our
single database model, our systems provide secure, real-time access to all information across multiple
applications for all those needing such access, including physicians, nurses, laboratory technicians,
pharmacists, clinicians and other users. The enterprise-wide, fully integrated nature of our system also
allows customers to monitor user access to information for purposes of compliance with new federal and
state privacy regulations.
Maintain Commitment to Customer Oriented Operating Philosophy. A key factor in our success
has been our focus on customer service and support. We make available to our customers experienced
support teams that can assist with any question or problem. We currently have a greater than one to one
support staff to customer ratio. Our support teams are extensively trained, and our employees are
generally promoted from within so that they have a thorough knowledge of our system and a commitment
to our culture. Because all of our customers use the same version of our system, our support teams can be
more effective by maintaining a complete understanding of a single system. As part of our commitment to
system support, we actively solicit customer feedback regarding ways in which we can improve the
effectiveness and efficiency of our systems. To further this goal, we have organized our customers into a
national user group to promote the exchange of information regarding our system and to identify product
enhancements based on our customers' operational experiences. We believe our user group concept is a
key component of our success by positively impacting customer satisfaction and retention and by
enhancing product development and system functionality. We will continue to focus on our national user
group as a key component to our goal of maintaining and growing our customer base and market share.
Expand Presence in Target Market. We will continue to target small to midsize domestic
hospitals of 300 or fewer acute care beds. We believe this market of approximately 4,100 community
hospitals nationwide has been traditionally overlooked and underserved by other healthcare technology
companies. In addition, a number of our customers are small specialty hospitals that focus on discrete
medical areas such as surgery, rehabilitation and psychiatry. We intend to continue gaining customers
from this market segment. Our system can help these smaller hospitals reduce costs and increase their
operating efficiencies. We believe our personalized marketing approach and emphasis on customer
relationships are attractive to the management of these hospitals. We also believe our system is well-
suited to hospitals of this size because they typically demonstrate a greater commitment than larger
hospitals to the concept of an enterprise-wide, fully integrated system. While 93% of our current
customers are hospitals of 100 acute care beds or less, we believe there is a substantial opportunity in the
future to increase our market share among hospitals with 100 to 300 acute care beds. In addition, we will
continue to sell additional services and software products to our existing customers who have not
purchased our complete package of services and software applications.
Emphasize Recurring Revenue Opportunities. In addition to revenues from new system
installations, we are developing sources of recurring revenues. Our current principal source of recurring
revenues is our support and maintenance fees paid by existing customers. As our customer base grows,
our recurring revenues from support and maintenance fees should also grow. We believe growth in
recurring revenues will also come from our outsourcing services, which we market to our existing
customers as well as new customers. These services include electronic billing, patient statement
processing, business office outsourcing, ISP services and web site hosting. We also provide our software
products on an ASP basis. When we provide ASP services, we maintain a customer's computer server in
our facility and provide our system to the customer through remote access. Instead of the one-time system
purchase price, these customers pay a monthly fee for the term of the ASP customer agreement,
generating recurring revenues.
5
Our Products and Services
Recent Developments
We completed development of the following new products during 2003, and initial installations in
customer facilities occurred during the fourth quarter of 2003:
ImageLinkTM. ImageLinkTM is a fully integrated medical imaging solution for the capture,
manipulation, annotation and storage of high resolution digital radiologic images from multiple source
modalities. Designed to enhance the efficiency of diagnostic decision making, the system includes a full-
featured viewer with custom work lists organized to the requirements of individual radiologists. This
product receives digital images with accompanying information from various modalities including
Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Nuclear Medicine, Radiography and
Computed Radiography. ImageLinkTM fits seamlessly into the hospital’s information technology
infrastructure by sharing patient and order information with existing patient care and clinical applications.
This real-time link allows the update of ImageLinkTM work lists, identification of the appropriate
modality to be used, application of an electronic signature to “lock” the image and notification of
completed orders. The resulting annotated softcopy images offer the healthcare enterprise a more
complete electronic medical record that provides clinicians with secure and immediate access to
diagnostic images when and where they need them.
Medical Practice Patient Charting. The Medical Practice Patient Charting module expands the
information available on-line to practitioners by providing for the capture of patient assessments and
creation of a permanent electronic encounter record. Medical Practice Patient Charting, in conjunction
with existing document scanning and archival data repository products, produces a permanent electronic
patient encounter record that can include virtually any information desired. Designed to automate the
clerical functions associated with patient assessments, the module provides physician practices with a
flexible documentation solution that charts information in real-time and reduces the amount of paper that
must be stored. With Medical Practice Patient Charting, encounter information can be immediately and
securely accessed on-line at the physician office or the hospital.
Systems
We offer a full array of software applications designed to streamline the flow of information to
the primary functional areas of community hospitals in one fully integrated system. We intend to continue
to enhance our existing software applications and develop new applications as required by evolving
industry standards and the changing needs of our customers. Pursuant to our customer support
agreements, we provide all of our customers with software enhancements and upgrades typically twice
each year. See "--Support and Maintenance Services." These enhancements enable each customer,
regardless of its original installation date, to have the benefit of the most advanced CPSI products
available. Our software applications:
•
•
•
provide automated processes that improve clinical workflow and support clinical
decision-making;
allow healthcare providers to efficiently input and easily access the most current patient
medical data in order to improve the quality of care and patient safety;
integrate clinical, financial and patient information to promote efficient use of time and
resources, while eliminating dependence on paper medical records;
6
•
•
•
provide tools that permit healthcare organizations to analyze past performance, model
new plans for the future and measure and monitor the effectiveness of those plans;
provide for rapid and cost-effective implementation, whether through the installation of
an in-house system or through our ASP services; and
increase the flow of information by replacing centralized and limited control over
information with broad-based, secure access by clinical and administrative personnel to
data relevant to their functional areas.
Our software applications are grouped for support purposes according to the following functional
categories:
•
•
•
•
•
Patient Management
Financial Accounting
Clinical
Patient Care
Enterprise Applications
Due to the integrated nature of the CPSI system, our software applications are not marketed as
distinct products, and our sales force attempts to sell all applications to each customer as a single product.
New customers must purchase from us and install the core applications of patient management and
financial accounting and all hardware necessary to run these applications. In addition to the core
applications, customers may also acquire one or more of our clinical, patient care and enterprise
applications. Approximately one-third of our customers have purchased a combination of applications
that meet their enterprise-wide information technology needs.
The general functional categories, as well as the software applications in each of these categories,
are described below.
Patient Management. Our patient management software enables a hospital to identify a patient
at any point in the healthcare delivery system and to collect and maintain patient information throughout
the entire process of patient care on an enterprise-wide basis. The single database structure of our
software permits authorized hospital personnel to simultaneously access appropriate portions of a patient's
record from any point on the system. The patient management software performs the following functions:
7
Registration
•
records patient admissions, discharges and transfers
• manages patient status, room assignments and
recurring charges
• keeps information available to all hospital personnel in
formats designed for their particular requirements
Patient Accounting
•
records patient charges and maintains accounts receivable
information including aging, service charges and cash
receipts
Health Information
Management
Patient Index
Electronic Claims
Processing
Medical Practice
Management
• generates and processes insurance claims
•
•
supports the operational needs of the modern medical
records department including transcription, case
indexing/abstracting and statistical reporting
tracks deficiencies in a patient's chart and provides chart
location information
• maintains a master index of hospital patients and provides
immediate online access to patient financial and medical
data associated with a patient stay
• provides a computer-to-computer link with intermediaries
for Medicare and other payers for the submission of claims
•
•
supports patient account management and insurance
processing for single and multiple practices/clinics
supports both hospital-based and remote practices/clinics
We also offer the following optional products that may be purchased as part of our core patient
management suite:
Scheduling
Managed Care
Quality Improvement
• maintains all patient scheduling information
•
•
tracks patients enrolled in managed care plans and
conforms billing functions to such plans
automates hospital-wide total quality management and
reporting requirements for utilization activity, risk
management, infection surveillance and all accreditation
review functions
Financial Accounting. Our financial accounting software provides a variety of business office
applications designed to efficiently track and coordinate information needed for managerial decision-making.
The financial accounting software:
8
Executive Information
System
•
summarizes daily financial transactions regarding patient
revenues, receipts, census statistics and billing information
for ready access by hospital administrators
General Ledger
• provides timely, accurate, financial information generated
from daily hospital operations
•
formats financial statements to the specifications of each
user and is able to generate up to 999 different user-
defined reports
Accounts Payable
• processes vendor invoices and payments and their related
general ledger entries
Payroll/Personnel
•
•
calculates all employee wages and benefits for an
unlimited number of salaried and hourly employees
allocates employee time to user-defined cost centers
Time and Attendance
• uses touch screen time clocks to eliminate manual time
Electronic Direct
Deposits
Human Resources
Budgeting
Fixed Assets
Materials Management
entry
•
reduces effort of gathering employee time data and
increases access of managers to such data
• makes time records more accurate by identifying
employees through bar-coding and optional biometric
fingerprint technology
• provides for computerized bank deposits to meet payroll
and accounts payable needs
• provides for computerized employee files through
document/image scanning and data entry
•
•
•
•
•
•
allows for complete tracking of benefits and other
employee data through a variety of user-defined reports
tracks job applicant information to assist in the employee
recruiting and hiring process
allows for complete on-line budget preparation through
computerized access to historical data
allows access to information regarding hospital assets
including locations and depreciation scheduling
tracks the flow of materials throughout the hospital
automates the process of inventory control, materials
purchasing, stock requisitions and patient charging
9
Clinical. Our clinical software automates record keeping and reporting for many clinical
functions including laboratory, radiology, physical therapy, respiratory care, and pharmacy. These
products eliminate tedious paperwork, calculations and written documentation while allowing for easy
retrieval of patient data and statistics. Our clinical software:
Laboratory Information
Systems
• provides an interface to laboratory analytical instruments
in order to transfer results to nurse stations, mobile point-
of-care systems and remote physician offices
•
allows users to receive orders from any designated
location, process orders and report results and maintain
technical, statistical and account information
Laboratory Instrument
Interfaces
• provides an automated solution for reviewing test results
and completing patient orders
Radiology Information
Systems
•
•
•
•
reduces the amount of required manual data entry thereby
reducing the likelihood of human error
reduces time to process laboratory specimens
includes flash card printing, patient scheduling,
transcription, patient indexing by X-Ray film number,
film tracking and location
receives patient data, patient locations and other
interdepartmental communications support
ImageLinkTM
• provides a complete picture archiving and
communications system (PACS) with comprehensive
functionality designed to fit seamlessly with our other
applications
•
allows the realization of an electronic medical record
complete with diagnostic images
• provides physicians real time access to diagnostic images
via the internet through ChartLinkTM
10
Physical Therapy and
Respiratory Care
Pharmacy
•
communicates to nursing the appropriate procedures and
patient preparation instructions from orders entered into
the CPSI system
• keeps a journal of the orders received and processed
• handles a variety of processing tasks after a patient order
is reviewed
•
•
allows a department to customize its results to be sent
back to nursing
allows the hospital pharmacist to enter and fill physician
orders
• performs all of the functions related to patient charging,
general ledger upgrading, re-supply scheduling and
inventory reduction/statistics maintenance
•
improves patient care by monitoring drug/drug and
food/drug interactions, allergy contraindications, dosage
ranges and duplicate therapy
• produces drug education information for each patient in an
easy-to-read format
Patient Care. Our patient care applications allow hospitals to create computerized "patient files"
in place of the traditional paper file systems. This software enables physicians, nurses and other hospital
staff to improve the quality of patient care through increased access to patient information, assistance with
projected care requirements and feedback regarding patient needs. Our software also addresses current
safety initiatives in the healthcare industry such as the transition from written prescriptions and physician
orders to computerized physician order entry. Our patient care software:
Order Entry / Results
Reporting
automates the entry of patient charges
reduces "lost" charges and mistakes due to legibility
•
•
•
• provides interactive, real time status reports for orders
increases efficiency of nursing stations
Point-of-Care System
•
allows nurses to enter patient data into the network at the
patient's bedside thereby eliminating the duplicate entry of
information
• utilizes touch-screen and wireless technology
• makes patient information instantly available throughout
the entire hospital system
11
Patient Acuity
ChartLink TM
Medication Verification
Resident Assessment
Instruments
•
•
categorizes patients according to an assessment of the
acuity of the illness, severity of the symptoms, and
projected nursing dependency
allows nurses to project the total character and amount of
care that should be provided to each patient
• provides physicians with secure and interactive access to
patient information through a hospital's website
• provides for computerized physician order entry including
medication order entry
• verifies the accuracy of patient medication orders at a
patient's bedside by comparing scans of patient and
medication bar codes against the medication orders and
history for that patient
•
•
screens medication orders for possible patient allergies
and/or drug interactions
allows nursing staff to complete time consuming resident
reporting requirements in an expeditious and efficient
manner
• generates nursing care plans based on deficiencies in the
resident reports
Medical Practice Charting
• provides a permanent electronic encounter record for the
physician office
• provides patient charting customized to the specific needs
of each practice
Medical Practice Access
• provides physicians and their office administrators with
remote access to online, real time, secure patient data such
as insurance and billing information, diagnosis and
procedure coding, discharge summaries, pharmacy profiles
and other clinical and administrative information
Enterprise Applications. We provide software applications that support the products described
above and are useful to all areas of the hospital. These applications include: ad hoc reporting, automatic
batch and real-time system backups, an integrated fax system, archival data repository, document
scanning and Microsoft Office integration.
Home Health Information System. We offer a comprehensive information system for use in
home healthcare, which system incorporates certain of the applications described above. This system is
used primarily by hospitals with a CPSI information system that also have home health departments. Our
home health system provides an advanced solution that includes both home care patient
accounting/billing and remote home care documentation and care tracking. The system is designed,
developed and regularly enhanced to meet the needs and regulatory requirements that challenge home
healthcare.
12
Support and Maintenance Services
After a customer installs a CPSI system, we provide software application support, hardware
maintenance, continuing education and related services pursuant to a support agreement. The following
describes services provided to customers using CPSI systems.
Total System Support. We believe the quality of continuing customer support is one of the most
critical considerations in the selection of an information system provider. We provide hardware, technical
and software support for all aspects of our system which gives us the flexibility to take the necessary
course of action to resolve any issue. Unlike our competitors who use third-party services for hardware
and software support, we provide a single, convenient and efficient resource for all of our customers'
system support needs. In order to minimize the impact of a system problem, we train our customer service
personnel to be technically proficient, courteous and prompt. Because a properly functioning information
system is crucial to a hospital's operations, our support teams are available 24 hours a day to assist
customers with any problem that may arise. Customers can also use the Internet to directly access our
support system. This allows customers to communicate electronically with our support teams at any time.
With approximately 522 employees who provide customer service and support, we currently have a
greater than one to one support staff to customer ratio.
User Group. All of our customers are members of our user group from which we solicit
feedback regarding our products. We host a national user group meeting annually. We have also
organized several active regional user groups which meet on a semi-annual basis. These groups meet to
discuss and recommend product modifications and improvements which they then evaluate and prioritize.
Upon confirming that the desired improvements are technically feasible, we agree to allocate a significant
amount of programming time each year to undertake the requested modification or improvement. The
majority of our product enhancements originate from suggestions from our customers through the user
group structure.
Software Releases. We are committed to providing our customers with software and technology
solutions that will continue to meet their information system needs. To accomplish this purpose, we
continually work to enhance and improve our application programs. As part of this effort, we typically
release two software updates each year at no additional cost to our customers. We design these
enhancements to be seamlessly integrated into each customer's existing CPSI system. The benefit of these
enhancements is that each customer, regardless of its original installation date, uses the most advanced
CPSI software available. Through this process, we can keep our customers up-to-date with the latest
operational innovations in the healthcare industry as well as changing governmental regulatory
requirements. Another benefit of this "one system" concept is that our customer service teams can be
more effective in responding to customer needs because they maintain a complete understanding of and
familiarity with the one system that all customers use.
Purchasing a new information technology system requires the expenditure of a substantial amount
of capital and other resources, and many customers are concerned that these systems will become obsolete
as technology changes. Our periodic product updates eliminate our customers' concerns about system
obsolescence. We believe providing this benefit is a strong incentive for potential customers to select our
products over the products of our competitors.
Hardware Replacement. As part of our customer service effort, we are also committed to
promptly replacing malfunctioning system hardware in order to minimize the effect of operational
interruptions. By providing all hardware used in our system, we believe we are better able to meet and
address all of the information technology needs of our customers.
13
Application Service Provider. In some circumstances, we offer ASP services to customers via
remote access telecommunications. As an application service provider, we store and maintain computer
servers dedicated to specific customers which contain all of such customers' critical patient and
administrative data. These customers access this information remotely through direct telecommunications
connections with these servers.
Internet Service Provider. As part of our total information solution, we can provide Internet
connection services to our customers. We also can provide web-site design and hosting services.
Forms and Supplies. We offer our customers the forms that they need for their patient and
financial records, as well as their general office supplies. Furnishing these forms and supplies helps us to
achieve our objective of being a one-source solution for a hospital's complete healthcare information
system requirements.
Outsourcing Services
Electronic Billing. We provide electronic billing for customers at prices competitive with other
electronic billing vendors. Once a customer processes patient insurance claims in our system, we then
perform the electronic billing function with no other participation by hospital staff. With this service,
customers need not prepare billing files or maintain interfaces with third-party software, thereby saving
the customer both time and money.
Statement Processing. Our customers may choose to have us prepare and distribute all patient
billing statements. We use our knowledge of a customer's collection system to produce statements without
requiring any actions on the part of the hospital data processing personnel. Because we can connect
directly with a customer's system, the customer is not required to build and transfer files to us. All system
enhancements are incorporated into the statement process without having to modify any third-party
vendor interface. Like the electronic billing outsourcing, this service saves the customer both time and
money.
Business Office Outsourcing. We offer customers the option of using us to perform their
primary business office functions, including patient billing and accounts receivable management. Using
this service allows customers to reduce costs by employing fewer full time administrative employees.
System Implementation and Training
Conversion Services. When a customer purchases our system, we convert its existing data to the
CPSI system. Our knowledge of hospital data processing, in conjunction with extensive in-house
technical expertise, allows us to accomplish this task in a cost effective manner. When we install a new
system, the data conversion has already occurred so that the system is immediately operational. Our goal
is for each customer to be immediately productive in order not to waste time and money on the costly and
inefficient task of maintaining the same data on parallel systems. Our services also relieve the hospital
staff of the time-consuming burden of data conversion.
Training. In order to integrate the new system and to ensure its success, we spend
approximately three weeks providing individualized training on-site at each customer's facility at the time
of installation. We directly train all hospital users, including staff members and healthcare providers,
during all hospital shifts in the use of hardware and software applications. In contrast, some of our
competitors train only a hospital's training staff at an off-site location. We employ nurses and medical
technicians in addition to our technical training staff in order to help us communicate more effectively
with our customers during the training process.
14
Technology
Operating Systems and Server Platform. We utilize Intel-based servers running industry
standard "open systems," including Unix and Microsoft Windows 2000 Server operating systems.
ClientWare® Networking. Our ClientWare® application integrates the UNIX and Microsoft
operating systems. This integration brings together the strengths of both operating environments. The
processing power of UNIX combined with the communication capabilities of Microsoft Windows creates
an information system that allows the use of familiar "point and click" processing. This architecture also
facilitates integration of other Microsoft software and provides expanded opportunities for the inclusion
of new technologies without sacrificing system reliability or performance.
Wireless Technology. Traditional workstations were designed around access to electrical and
network outlets. We now use wireless networking technology to connect computers to the CPSI system.
This allows customers to use mobile computers and to place stationary computers in locations for
optimum convenience and ease of use. We incorporate wireless laptop and hand held computers into our
system. Convenient to carry and use, these mobile computers allow effective data collection and real-time
access to patient information from practically anywhere in the hospital. Information efficiently collected
will then be more quickly accessible by other caregivers throughout the hospital.
Point-of-Care Stations. Since 1990, we have used "point-of-care stations" which allow nurses
to enter information into the system at a patient's bedside. These stations consist of compact computers on
individual data entry stations that are lightweight, durable and easy to maneuver. We incorporate our
wireless networking capabilities into these stations in order to provide extended range and mobility.
Touch Sensitive Displays. Data entry is made easier through the use of touch sensitive displays.
With this technology work areas are free of the traditional keyboard and mouse associated with most
personal computers. Touch screens are also more efficient for users who are not proficient in computer
skills.
Voice Transcription. We offer voice transcription software capable of learning an individual
physician's speech patterns. Computerized transcription stations can then transcribe documents dictated
by physicians. The resulting reduction in time required to input patient data and prepare patient
documents positively impacts the quality of patient care by providing caregivers with faster access to the
most up-to-date patient information.
Biometric Recognition. As unique as each individual, a fingerprint cannot be duplicated,
making it one of the most secure methods of verifying a person's identity. Because of the sensitivity of
healthcare information and proposed federal security requirements, we have incorporated licensed
fingerprint identification technology as an option for our systems. When a user signs on to the system, he
or she must scan his or her fingerprint as well as enter a traditional password. The system rapidly
responds with the confirmation or rejection of the user's identity.
Research and Development
We are continually working to improve and enhance the CPSI system and to develop new
products and services for our system. The primary source of ideas for improvements to our products and
services comes from our customers through our national user group. We believe our interaction with
customers and their communication with each other is the most efficient way to learn about and respond
to changes in the healthcare operating environment. This approach to research and development allows us
to quickly adapt to technology advances and improve our products and services to better serve the needs
15
of our customers. Our management and customer support and service teams play a significant role in
product development by continually monitoring the needs and desires of our customers and our market. In
addition to our customer support and service teams, we currently have five employees whose primary
function is the development of financial and enterprise software products and ten employees whose
primary function is the development of clinical software products. Finally, we currently have eight
research and development employees whose dedicated function is to develop new uses for and
applications of technology available in the marketplace.
Customers, Sales and Marketing
Target Market. The target market for our information system consists of small and midsize
hospitals of 300 or fewer acute care beds. In the United States, there are approximately 4,100 hospitals in
this size range. In addition, we market our products to small specialty hospitals in the United States that
focus on discrete medical areas such as surgery, rehabilitation and psychiatry. As of March 10, 2004, we
had installed our system in over 490 facilities in 45 states and the District of Columbia. Our customers
historically have consisted of hospitals with 100 or fewer acute care beds. Approximately 93% of our
existing customers are hospitals of this size. Our goal is to increase sales to hospitals consisting of 100 to
300 acute care beds while maintaining our competitive position in the under 100 bed market segment.
The following table provides information about our current customer base as of March 10, 2004:
Less than 100 beds
100-200 beds
201-300 beds
Total
Current CPSI
Customers
461
30
3
494
Percentage of
CPSI Customers
93%
6
1
100%
Sales Staff. Most of our new customers are referrals from our existing customers, thereby
reducing the need for a large sales force. Currently, we have 17 employees dedicated to direct sales, nine
of whom concentrate on new prospects, and eight of whom are responsible for the sale of additional
products and services to existing customers. We hire our sales representatives from our existing
employees. Our current sales representatives have an average of 9.5 years of prior experience in
installation, training and customer support. While centrally based at our headquarters in Mobile, our sales
representatives have defined geographic territories in the United States in which to target new customers.
A significant portion of the compensation for all sales personnel is performance based.
Marketing Strategy. Our primary marketing strategy is to generate referrals from our existing
customers and directly solicit potential users through presentations at industry seminars and trade shows.
We also advertise in various healthcare industry trade publications. For hospitals that we have targeted as
potential customers, most of our direct sales efforts involve site visits and meetings with hospital
management. The typical sales cycle of a healthcare information system usually takes six to eighteen
months from the time of initial contact to the signing of a contract. Therefore, we believe it is important
for our sales staff to dedicate a substantial amount of time and energy to building relationships with
potential new customers. We do not conduct extensive marketing activities and promotions because
hospitals are easily identified, finite in number and generally send a request for proposal to vendors when
they contemplate the purchase of a hospital information system.
16
Competition
The market for our products and services is competitive, and we expect additional competition
from established and emerging companies in the future. Our market is characterized by rapidly changing
technology, evolving user needs and the frequent introduction of new products. We believe the principal
competitive factors that hospitals consider when choosing between us and our competitors are:
•
•
•
•
•
•
•
product features, functionality and performance;
level of customer service and satisfaction;
ease of integration and speed of implementation;
product price;
knowledge of the healthcare industry;
sales and marketing efforts; and
company reputation.
Our principal competitors are Medical Information Technology, Inc., or "Meditech," and
Healthcare Management Systems, Inc., or "HMS." Meditech and HMS compete with us directly in our
target market of small and midsize hospitals. These companies offer products and systems that are
comparable to our system and address the needs of hospitals in the markets we serve.
Our secondary competitors include McKesson Corporation, Quadramed Corp., Cerner
Corporation and Siemens Corporation. These companies are significantly larger than we are, and they
typically sell their products and services to larger hospitals outside of our target market. However, they
will sometimes compete directly with us. We also face competition from providers of practice
management systems, general decision support and database systems and other segment-specific
applications, as well as from healthcare technology consultants. Any of these companies as well as other
technology or healthcare companies could decide at any time to specifically target hospitals within our
target market.
A number of existing and potential competitors are more established than we are and have greater
name recognition and financial, technical and marketing resources than we have. Products of our
competitors may have better performance, lower prices and broader market acceptance than our products.
We expect that competition will continue to increase.
Internal Management Controls
We have developed and maintain an automated enterprise management system which permits us
to manage not only all of our internal management, accounting and personnel functions, but also all
information relating to each customer's information system. Our system maintains detailed records of all
information regarding each customer's system, including all system specifications, service history and
customer communications, among other things. This internal control system helps us to more effectively
respond to customer support needs through complete and current system information and through
situation-based problem solving.
17
Intellectual Property
We regard some aspects of our internal operations, software and documentation as proprietary,
and rely primarily on a combination of contract and trade secret laws to protect our proprietary
information. We believe, because of the rapid pace of technological change in the computer software
industry, trade secret and copyright protection is less significant than factors such as the knowledge,
ability and experience of our employees, frequent software product enhancements and the timeliness and
quality of support services. We cannot guarantee that these protections will be adequate or that our
competitors will not independently develop technologies that are substantially equivalent or superior to
our technology.
We do not believe our software products or other CPSI proprietary rights infringe on the property
rights of third parties. However, we cannot guarantee that third-parties will not assert infringement claims
against us with respect to current or future software products or that any such assertion may not require us
to enter into royalty arrangements or result in costly litigation.
Employees
As of March 10, 2004, we had 651 employees, all but four of whom are located at our offices in
Mobile, Alabama. Our employees can be grouped according to the following general categories: 416 in
financial and clinical software services and support, 111 in information technology services and support,
59 in programming, 29 in sales and marketing and 36 in administration. We have 23 employees who
perform research and development activities. These employees are included within the functional areas of
financial and clinical software services and support and information technology services and support. Our
general practice is to recruit recent college graduates for entry-level positions and then promote these
individuals within the organization to fill vacancies in higher positions. We also hire nurses and other
medically-trained professionals in connection with our support services.
Since 1991, we have maintained a non-qualified profit sharing plan under which all full-time
employees with three years of uninterrupted service are eligible to participate, other than executive
officers and commissioned salespeople. The plan is designed to provide each eligible employee with
periodic cash bonuses based on our profitability. Each eligible employee receives a pro rata share of the
amount of cash distributed under the profit sharing plan based on the amount of their base salary
compared to the sum of the salaries of all participating employees. Our profit sharing plan is not a
qualified plan for tax purposes or a guaranteed benefit. Contributions to the plan are made periodically at
the discretion of the Board of Directors. During 2003, we distributed approximately $1.1 million under
this profit sharing plan. We plan to continue to make distributions under the profit sharing plan based on
our profitability.
We are fortunate to have a high rate of employee retention, with our senior management having
an average tenure in excess of 15 years. Our performance depends in significant part on our ability to
attract, train and retain highly qualified personnel. None of our employees are represented by a labor
union, and we believe our relations with our employees are good.
18
Executive Officers
The Executive Officers of CPSI serve at the pleasure of the Board of Directors. Set forth below
is a list of the current Executive Officers of CPSI and a brief explanation of their principal employment
during the last five (5) years.
David A. Dye – President and Chief Executive Officer. David A. Dye, age 34, has served as
our President and Chief Executive Officer since July 1999. He was elected as a director in March 2002.
Mr. Dye began his career with us in May 1990 as a Financial Software Support Representative. From that
time until June 1999, he worked for us in various capacities, including as Manager of Financial Software
Support, Director of Information Technology and most recently as our Vice President supervising the
areas of sales, marketing and information technology.
J. Boyd Douglas – Executive Vice President and Chief Operating Officer. J. Boyd Douglas,
age 37, has served as our Executive Vice President and Chief Operating Officer since July 1999. He was
elected as a director in March 2002. Mr. Douglas began his career with us in August 1988 as a Financial
Software Support Representative. From May 1990 until November 1994, Mr. Douglas served as Manager
of Electronic Billing, and from December 1994 until June 1999, he held the position of Director of
Programming Services.
M. Stephen Walker – Vice President--Finance, Chief Financial Officer, Secretary and
Treasurer. M. Stephen Walker, age 54, has served as our Vice President--Finance, Chief Financial
Officer, Secretary and Treasurer since July 1999. From February 1991 until June 1999, Mr. Walker
served as our controller with primary responsibility for all of our accounting functions.
Victor S. Schneider – Vice President--Sales and Marketing. Victor S. Schneider, age 45, has
served as our Vice President--Sales and Marketing since July 1999. Mr. Schneider is responsible for
overseeing all of our sales and marketing efforts. Mr. Schneider began his career with us in June 1983 as
Sales Manager. He served in that capacity until January 1997 when he was promoted to Sales Director.
Mellissa A. Hammons – Vice President--Financial Software Services. Mellissa A. Hammons,
age 47, has served as our Vice President--Financial Software Services since July 1999. Ms. Hammons is
responsible for overseeing all aspects of the installation and support of our financial software products.
Since beginning her career with us in 1985 as a Financial Software Support Representative, Ms.
Hammons has worked in various positions in our Financial Software Services Division including
Manager and Director of that division.
Thomas W. Peterson – Vice President--Clinical Software Services. Mr. Peterson, age 52, has
served as our Vice President--Clinical Software Services since July 1999. Mr. Peterson is responsible for
overseeing all aspects of the installation and support of our clinical software products. Since beginning his
career with us in 1988 as a Clinical Software Support Representative, Mr. Peterson has worked in various
positions in our Clinical Software Services Division including Manager and Director of that division.
Patrick A. Immel – Vice President--Information Technology Services. Patrick A. Immel, age
33, has served as our Vice President--Information Technology Services since January 2000. Mr. Immel is
responsible for overseeing technical hardware and support and hardware research and development. Mr.
Immel began his career with us in July 1993 as a Financial Software Support Representative. Since that
time, Mr. Immel has served as a programmer, Manager of Technical Support and most recently as
Director of Information Technology Services.
19
Company Website
The Company maintains a website at http://www.cpsinet.com. The Company makes available on
its website, free of charge, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and all amendments to those reports, as soon as it is reasonably practicable after
such material is electronically filed with the Securities and Exchange Commission. The Company is not
including the information contained on or available through its website as a part of, or incorporating such
information into, this Annual Report on Form 10-K.
ITEM 2.
PROPERTIES
Our corporate headquarters and executive offices are located on approximately 28 acres in
Mobile, Alabama. We occupy approximately 117,500 square feet of space in ten buildings. Our main
building consists of approximately 66,000 square feet of space. We also have eight additional buildings
each consisting of approximately 6,000 square feet. Each of these smaller buildings is designed to
accommodate a team of employees assigned to install and support a particular software application. We
also occupy a building consisting of approximately 3,500 square feet of space which houses our eight
research and development employees dedicated to developing new uses for and applications of available
technology.
We lease approximately 16.5 acres and all of our buildings (other than the research and
development building) from CP Investments, Inc., an Alabama corporation, the stockholders of which are
John Morrissey, John Heyer, Bob O'Donnell, Elissa Stillings, Kevin P. Wilkins, Tabitha M. Wilkins
Olzinski, Ellen M. Harvey, Michael K. Muscat, Jr. and Susan M. Slaton. All of these individuals are
either stockholders of CPSI, or, in the case of Ms. Stillings, the spouse of a stockholder. Our leases with
CP Investments, Inc. expire at various times between April 2012 and June 2013. The research and
development building is leased from DJK, LLC, a limited liability company owned by Dennis Wilkins, a
principal stockholder and a director of CPSI. Our lease with DJK, LLC also expires in April 2012. We
also own 11.3 acres of undeveloped real property adjacent to our primary premises in order to
accommodate future growth.
We believe our existing facilities will be sufficient to meet our needs until the end of 2004. At that
time we believe we will need to construct additional facilities on the undeveloped portion of our campus
in order to accommodate our expansion needs.
ITEM 3.
LEGAL PROCEEDINGS
From time to time, we are involved in routine litigation that arises in the ordinary course of
business. We currently are involved in a litigated dispute relating to the installation of a hospital
information system that, if resolved unfavorably, could have a negative impact on our quarterly earnings
at some point in the future. However, this dispute should not have a material adverse effect on our
business or financial condition. We are not currently involved in any other litigation that we believe
could reasonably be expected to have a material adverse effect on our business, financial condition or
results of operations.
ITEM 4.
SUBMISSION OF MATTERS TO A VOTE OF SECURITY-HOLDERS
None.
20
PART II
ITEM 5.
MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS
Market for CPSI Common Stock
At March 10, 2004, CPSI had 83 stockholders of record (which does not include the number of
beneficial owners whose shares are held in "street" names by nominees who are record holders) and
10,489,849 shares of CPSI common stock outstanding.
CPSI common stock is traded in the over-the-counter market and prices are quoted on the
NASDAQ Stock Market under the symbol "CPSI." The reported sales price range for CPSI common
stock during all four quarters of 2003 and the third and fourth quarters of 2002 (the first two quarters after
the completion of our initial public offering (“IPO”) in May 2002) are shown below:
Fiscal Year Ended
December 31, 2003
Fiscal Year Ended
December 31, 2002
Quarter
High
Low
Quarter
High
Low
First
Second
Third
Fourth
$25.93
$20.78
First
17.80
Second
--
--
--
--
14.04
Third
$25.25
$17.35
14.40
Fourth
26.85
19.00
25.05
21.75
20.35
The last reported sales price of CPSI Common Stock as reported on the NASDAQ Stock Market
on March 10, 2004 was $18.35.
Dividends
During 2002, we paid a total of $16.9 million to our pre-IPO stockholders in connection with the
IPO and our related conversion from an S corporation to a C corporation. During 2003, we paid an
additional $250,000 to these pre-IPO stockholders.
During the second quarter of 2003, we paid our first dividend on our common stock to our post-
IPO stockholders. In the second, third and forth quarters of 2003, we paid a dividend in the amount of
$0.085 per share. On February 3, 2004, we announced a dividend for the first quarter of 2004 in the
amount of $0.12 per share. We believe that paying dividends is an effective way of providing an
investment return to our stockholders and a beneficial use of our cash.
21
ITEM 6.
SELECTED FINANCIAL DATA
2003
2002
2001
2000
1999
Year ended December 31,
INCOME DATA:
Total sales revenues
Total costs of sales
Gross profit
Total operating expenses
Operating income
Total other income
Income before taxes
Income taxes
Net income
$ 81,303
48,405
32,898
20,352
12,546
338
12,884
5,018
$ 7,866
(in thousands except for share and per share data)
$ 49,222
31,487
17,735
13,080
4,655
236
4,891
-
$ 4,891
$ 73,744
42,925
30,819
18,750
12,069
552
12,621
1,971
$ 10,650
$ 59,666
36,242
23,424
14,948
8,476
204
8,680
-
$ 8,680
$ 50,530
29,895
20,635
11,894
8,741
196
8,937
-
$ 8,937
Net income per share - basic
$ 0.75
$ 1.06
$ 0.93
$ 0.53
$ 0.96
Net income per share - diluted
$ 0.75
$ 1.06
$ 0.93
$ 0.53
$ 0.96
Weighted average shares
outstanding:
Basic
Diluted
Pro forma income data:
Historical income before taxes
Pro forma income taxes
Pro forma net income
Pro forma net income per share –
basic
Pro forma net income per share –
diluted
BALANCE SHEET DATA
Cash and cash equivalents
Working capital
Total assets
Total current liabilities
Note payable
Total stockholders' equity
10,488,406
10,536,929
10,024,438
10,061,765
9,288,000
9,288,000
9,288,000
9,288,000
9,288,000
9,288,000
$ 12,621
4,577
$ 8,044
$ 8,680
3,231
$ 5,449
$ 4,891
1,826
$ 3,065
$ 8,937
3,324
$ 5,613
$ 0.80
$ 0.59
$ 0.33
$ 0.60
$ 0.80
$ 0.59
$ 0.33
$ 0.60
2003
2002
2001
2000
1999
As of December 31,
(in thousands)
$ 9,473
19,610
31,204
5,452
-
25,752
$ 6,352
14,812
28,909
8,430
-
20,479
$ 2,019
5,667
17,251
6,551
664
10,036
$ 1,033
4,658
14,515
5,810
749
7,956
$ 980
6,735
14,374
4,421
889
9,065
(1)
(2)
CPSI operated as an S corporation through May 20, 2002 and, as such, was not subject to federal and
certain state income taxes.
Pro forma information reflects the provision for income taxes that would have been recorded had CPSI
been a C corporation during all of the periods presented.
22
ITEM 7.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion of our financial condition and results of operations in
conjunction with "Selected Financial Data" and our financial statements and the related notes included
elsewhere in this Annual Report. This discussion and analysis contains forward-looking statements that
involve risks, uncertainties and assumptions. Our actual results may differ materially from those
anticipated in these forward-looking statements as a result of many factors, including but not limited to
those set forth under "Risk Factors" and elsewhere in this Annual Report.
Background
CPSI was founded in 1979 and specializes in delivering comprehensive healthcare information
systems and related services to community hospitals. Our systems and services are designed to support
the primary functional areas of a hospital and to enhance access to needed financial and clinical
information. Our comprehensive system enables healthcare providers to improve clinical, financial and
administrative outcomes. Our products and services provide solutions in key areas, including patient
management, financial management, patient care and clinical, enterprise and office automation.
We sell a fully integrated, enterprise-wide financial and clinical hospital information system
comprised of all necessary software, hardware, peripherals, forms and office supplies, together with
comprehensive customer service and support. We also offer outsourcing services, including electronic
billing submissions, patient statement processing and business office functions, as part of our overall
information system solution.
Our system currently is installed and operating in over 490 hospitals in 45 states and the District
of Columbia. Our customers historically have consisted of community hospitals with 100 or fewer acute
care beds. However, we also serve and are targeting for growth the market consisting of hospitals with
100 to 300 acute care beds.
Overview
We have achieved a compounded annual growth rate in revenues of approximately 20.0% over
the past five years. We did not achieve this growth rate in 2003, which we believe is the result of factors
that affected our industry. 2003 was a notably difficult year financially for community hospitals for
several reasons, including a weak Medicare and Medicaid reimbursement environment, high salary costs
due to a nationwide shortage of clinical professionals such as nurses and pharmacists, and lower than
anticipated patient admissions. The difficult year for our target market led to a challenging year for CPSI.
Many hospitals delayed making significant information technology purchases due to lack of available
capital. Although we added a record 48 new hospital clients in 2003 (ordinarily a positive performance
indicator), most hospitals approved purchases for the minimum amount of software needed to begin the
installation of an integrated system. These smaller purchases caused the size of our average installation
contract (another key performance indicator for our business) to decrease from approximately $650,000 in
2002 to approximately $500,000 in 2003.
Despite this challenging environment, we had another successful year financially. Our gross
revenues increased ten percent over 2002, while our bottom line remained constant. Cash flow from
operations and total cash collections reached record highs, eclipsing net income and gross revenues,
respectively, for the year. We continue to believe that our strong cash performance reflects both the
quality of our customer service and our conservative revenue recognition practices. Also, our “win rate”
in competing against other companies for sales to new hospitals continued to be very strong in 2003,
23
exceeding the rate we achieved in 2002. This is a key performance indicator that we look at in assessing
the strength of our business from a competitive standpoint, and our results in 2003 strongly support the
confidence we have in our business and the quality of the products and services we offer.
As a result of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003,
community hospitals are looking forward to substantially improved Medicare reimbursement beginning in
2004. In the past, Medicare’s payment formula has created a disproportionate burden on smaller,
community-based hospitals, which also typically depend on Medicare for a greater share of their payer
mix than larger, urban facilities. The new medicare legislation rectifies some of this imbalance, raising
Medicare reimbursements to rural hospitals by an estimated $25 billion over the next ten years. We
believe that once community hospitals begin to feel the financial effects of this legislation, we will be in a
good position to continue to grow our business.
Revenues
System Sales. Revenues from system sales are derived from the sale of information systems
(including software, conversion and installation services, hardware, peripherals, forms and office
supplies) to new customers and from the sale of new or additional products to existing customers. We do
not record revenue upon execution of a sales contract. Upon signing a contract to purchase a system from
us, each customer pays a non-refundable 10% deposit that is recorded as deferred revenue. The customer
then pays 40% of the purchase price for the software and the related installation, training and conversion
when we install the system and commence training on-site at the customer's facility, which is likewise
recorded as deferred revenue. When the system begins operating in a live environment, the remaining
50% of the system purchase price is payable, and we recognize revenue for the total amount of the
purchase price for software and related services. Revenues derived from installation of additional
software applications are generally recognized upon installation. Revenues from the sale of hardware,
forms and supplies are recognized upon the shipment of the product to the customer.
Support and Maintenance. We also derive revenues from the provision of system support
services, including software application support, hardware maintenance, continuing education and related
services. Support services are provided pursuant to a support agreement under which we provide
comprehensive system support and related services in exchange for a monthly fee based on the services
provided. The initial term of these contracts ranges from one to seven years, with a typical duration of
five years. Upon expiration of the initial term, these contracts renew automatically from year-to-year
thereafter until terminated. Revenues from support services are recognized in the month when these
services are performed.
We provide our products to some customers as an application service provider, or "ASP." We
provide ASP services on a remote access basis by storing and maintaining servers at our headquarters
which contain customers' patient and administrative data. These customers then access this data remotely
in exchange for a monthly fee. In addition, as part of our total information solution, we also serve as an
Internet service provider, or "ISP," for some of our customers for a monthly fee. We also provide web-site
design and hosting services if needed. Revenues from our ASP and ISP services are recognized in the
month when these services are delivered.
Outsourcing Revenues. We began offering outsourcing services in January 1999. Revenues
from outsourcing services have increased rapidly since that time. We expect outsourcing revenues to
continue to grow at a faster rate than our systems and services revenues. Our outsourcing services include
electronic billing, statement processing and business office outsourcing (primarily accounts receivable
management). All of these outsourcing services are sold pursuant to one year customer agreements, with
24
automatic one year renewals until terminated. Revenues from outsourcing services are recognized when
these services are performed.
Costs of Sales
System Sales. The principal costs associated with the design, development, sale and installation
of our systems are employee salaries, benefits, travel expenses and certain other overhead expenses. For
the sale of equipment we incur costs to acquire these products from the respective distributors or
manufacturers, as the case may be. Costs are deferred and recognized as an expense at the time the related
revenues are recognized on a completed contract basis. However, at December 31, 2003, 2002 and 2001,
no system sales related costs were deferred as all contracts were deemed to be substantially complete, or
such amounts were not considered to be material.
Support and Maintenance. The principal costs associated with our system support and
maintenance services are employee salaries, benefits and certain other overhead expenses. Costs are
expensed as incurred and are not deferred.
We have the same employee groups providing both system installations and support and
maintenance services. Salary related expenses are allocated between cost of system sales and cost of
support and maintenance services based upon an estimate of the percentage of time employees spend
performing each function.
Outsourcing. The principal cost related to our statement outsourcing is postage. The principal
costs related to our electronic billing outsourcing are employee related expenses, such as salaries and
benefits, and long distance telecommunication fees. Supplies and forms are additional significant costs
associated with our outsourcing services. Costs are expensed as incurred and are not deferred.
25
Results of Operations
The following table sets forth certain items included in our results of operations for each of the
three years in the period ended December 31, 2003, expressed as a percentage of our total revenues for
these periods:
INCOME DATA:
Sales revenues:
System sales
Support and maintenance
Outsourcing
Total sales revenues
Costs of sales:
System sales
Support and maintenance
Outsourcing
Total costs of sales
Gross profit
Operating expenses:
Sales and marketing
General and administrative
Total operating expenses
Operating income
Other income (expense):
Interest income
Miscellaneous income
Interest expense
Total other income
2003
Year ended December 31,
2002
2001
Amount
% Sales
Amount
% Sales
Amount
% Sales
$ 39,708
34,567
7,028
81,303
48.9%
42.5
8.6
100.0
$ 38,309
30,246
5,189
73,744
51.9%
41.0
7.1
100.0
$ 30,350
25,823
3,493
59,666
50.8%
43.3
5.9
100.0
28,045
16,101
4,259
48,405
32,898
34.5
19.8
5.2
59.5
40.5
25,838
13,905
3,182
42,925
30,819
35.0
18.9
4.3
58.2
41.8
22,499
11,634
2,109
36,242
23,424
37.7
19.5
3.5
60.7
39.3
6,125
14,227
20,352
12,546
7.5
17.5
25.0
15.5
5,933
12,817
18,750
12,069
8.0
17.4
25.4
16.4
5,105
9,843
14,948
8,476
8.6
16.5
25.1
14.2
216
122
-
338
0.3
0.1
0.0
0.4
214
362
(24)
552
0.3
0.5
0.0
0.8
126
154
(76)
204
0.2
0.2
-0.1
0.3
Income before taxes
12,884
15.9
12,621
17.2
8,680
14.5
Income taxes
5,018
6.2
1,971
2.7
-
-
Net income
$ 7,866
9.7%
$ 10,650
14.5%
$ 8,680
14.5%
2003 Compared to 2002
Revenues. Total revenues increased by 10.2% or $7.6 million to $81.3 million for 2003 from
$73.7 million for 2002.
System sales revenues increased by 3.7% or $1.4 million to $39.7 million in 2003 from $38.3
million in 2002. The increase in system sales revenues was attributable to an increase in the number of
new customer installations and an increase in the purchase of additional products by existing customers.
No costs relating to system sales were deferred under our completed contract method of accounting at
December 31, 2003 or 2002 as all contracts were deemed to be substantially complete.
26
Our 3.7% growth rate in system sales is less than the 23.6% growth rate we achieved from 2001
to 2002. We experienced slowed growth in system sales revenues during 2003 because of adverse
financial conditions affecting community hospitals, including a weak Medicare and Medicaid
reimbursement environment, high salary costs due to a nationwide shortage of clinical professionals such
as nurses and pharmacists, and lower than anticipated patient admissions. Many hospitals delayed
making significant information technology purchases due to lack of available capital. Although we added
a record 48 new hospital clients in 2003, most hospitals approved purchases for the minimum amount of
software needed to begin the installation of an integrated system. These smaller purchases caused the size
of our average installation contract to decrease from approximately $650,000 in 2002 to approximately
$500,000 in 2003.
Support and maintenance revenues increased by 14.3% or $4.3 million to $34.6 million in 2003
from $30.2 million in 2002. The increase in support and maintenance revenues was attributable to an
increase in recurring revenues as a result of a larger customer base. We had 490 customers at December
31, 2003, compared to 444 at December 31, 2002. ASP services revenues increased by 21.4% or $0.4
million and ISP services revenues increased by 20.8% or $0.1 million.
Outsourcing revenues increased by 35.4% or $1.8 million to $7.0 million in 2003 from $5.2
million in 2002. We experienced an increase in outsourcing revenues as a result of continued growth in
customer demand for electronic billing and statement outsourcing services. Statement outsourcing
revenues increased 17.5% and electronic billing revenues increased 36.4%. We were providing business
outsourcing services to four customers at December 31, 2003.
Costs of Sales. Total costs of sales increased by 12.8% or $5.5 million to $48.4 million in 2003
from $42.9 million in 2002. As a percentage of revenues, cost of sales increased to 59.5% for 2003 from
58.2% for 2002.
Cost of system sales increased by 8.5% or $2.2 million to $28.0 million for 2003 from $25.8
million for 2002. This increase was caused primarily by an increase in travel expenses of $0.6 million as a
result of a combination of factors including an increase in the sale of add-on clinical programs requiring
larger installation teams and installations in geographic locations with higher travel costs. Additionally,
payroll related expenses increased $1.0 million as a result of increased average employee headcount
needed to support increasing sales volume. Cost of equipment also increased by $0.2 million as a direct
result of our increase in system sales. Cost of software increased by $0.4 million as compared to 2002
because of a settlement payment from a software vendor in 2002 that caused the software costs that year
to be unusually low. The gross margin on system sales decreased to 29.4% for 2003 from 32.6% for
2002.
Cost of support and maintenance increased by 15.8% or $2.2 million to $16.1 million for 2003
from $13.9 million for 2002. This increase was caused primarily by an increase in payroll related
expenses of $1.9 million as a result of increased average employee headcount needed to support our
increasing customer base. Also, telecommunication expenses increased $0.1 million due to increased
utilization of our ISP services. The gross margin on support and maintenance revenues decreased to
53.4% for 2003 from 54.0% for 2002. The decrease in the gross margin was primarily due to the addition
of customer support personnel.
Our costs associated with outsourcing services increased 33.8% or $1.1 million to $4.3 million in
2003 from $3.2 million in 2002. Salary expense increased $0.5 million due to the full-year expense of
additional employees hired during 2002 to support our business office outsourcing services. Postage costs
increased $0.5 million as a result of a postal rate increase and an increase in transaction volumes of our
statement outsourcing services.
27
Sales and Marketing Expenses. Sales and marketing expenses increased 3.2% or $0.2 million to
$6.1 million in 2003 from $5.9 million in 2002. The increase was attributable to increased salary expense
of $0.2 million that resulted from the addition of sales personnel.
General and Administrative Expenses. General and administrative expenses increased by 11.0%
or $1.4 million to $14.2 million for 2003 from $12.8 million for 2002. The increase was due primarily to
an increase in employee group health insurance of $0.5 million and salary increases of $0.3 million.
Additional expense increases, which resulted from our continued growth, were $0.3 million for
depreciation, $0.1 million for telecommunications, and $0.2 million for facilities rent. The increases were
offset by a decrease of $0.6 million in bad debt expense. We have also experienced increased expenses of
$0.3 million in professional fees, investor relations and directors’ fees.
As a result of the foregoing factors, income before taxes increased by 2.1% or $0.3 million to
$12.9 million for 2003 from $12.6 million for 2002. This growth rate in income before taxes is less than
the growth rate we achieved from 2001 to 2002, primarily because of the slower growth in system sales
revenues described above.
2002 Compared to 2001
Revenues. Total revenues increased by 23.6% or $14.0 million to $73.7 million for 2002 from
$59.7 million for 2001.
System sales revenues increased by 26.2% or $7.9 million to $38.3 million in 2002 from $30.4
million in 2001. The increase in system sales revenue was attributable to an increase in the number and
size of new customer installations. No costs relating to system sales were deferred under our completed
contract method of accounting at December 31, 2002 or 2001 as all contracts were deemed to be
substantially complete.
Support and maintenance revenues increased by 17.1% or $4.4 million to $30.2 million in 2002
from $25.8 million in 2001. The increase in support and maintenance revenues was attributable to an
increase in recurring revenues as a result of a larger customer base, as well as an increase in ASP and ISP
services volume.
Outsourcing revenues increased by 48.6% or $1.7 million to $5.2 million in 2002 from $3.5
million in 2001. We experienced an increase in outsourcing revenues as a result of continued growth in
customer demand for electronic billing and statement outsourcing services. We initiated business office
outsourcing services during the first quarter of 2002 and were providing services to four customers at
December 31, 2002.
Costs of Sales. Total costs of sales increased by 18.4% or $6.7 million to $42.9 million in 2002
from $36.2 million in 2001. As a percentage of revenues, cost of sales decreased from 60.7% for 2001 to
58.2% for 2002.
Cost of system sales increased by 14.7% or $3.3 million to $25.8 million for 2002 from $22.5
million for 2001. This increase was caused primarily by an increase in travel expenses of $0.8 million as a
direct result of larger system installations requiring larger installation teams. Additionally, payroll related
expenses increased $1.4 million as a result of increased employee headcount needed to support increasing
sales volume. Cost of equipment also increased by $1.1 million as a direct result of our increase in system
sales. The gross margin on system sales increased to 32.6% for 2002 from 25.9% for 2001. The increase
in gross margin was due to an increase in the average size of systems installed in 2002 over 2001.
28
Cost of support and maintenance increased by 19.8% or $2.3 million to $13.9 million for 2002
from $11.6 million for 2001. This increase was caused primarily by an increase in payroll related
expenses of $2.0 million as a result of increased employee headcount needed to support our increasing
customer base. Also, telecommunication expenses increased $0.3 million due to increased utilization of
our ISP services. The gross margin on support and maintenance revenues decreased to 54.0% for 2002
from 54.9% for 2001. The decrease in the gross margin was primarily due to the addition of customer
support personnel necessary for the planned expansion of our customer base.
Our costs associated with outsourcing services increased 52.3% or $1.1 million to $3.2 million in
2002 from $2.1 million in 2001. Salary expense increased $0.5 million due to the hiring of additional
employees to support our business office outsourcing services. Postage cost increased $0.5 million and
cost of forms increased $0.1 million as a result of an increase in transaction volumes of our statement
outsourcing services.
Sales and Marketing Expenses. Sales and marketing expenses increased 15.7% or $0.8 million to
$5.9 million in 2002 from $5.1 million in 2001. The increase was attributable to increased commission
expense of $0.8 million that resulted from increased sales volumes.
General and Administrative Expenses. General and administrative expenses increased by 30.2%
or $3.0 million to $12.8 million for 2002 from $9.8 million for 2001. The increase was due primarily to
increases in employee related expenses of $1.1 million as a result of an increase in employees to 650 at
December 31, 2002 from 548 at December 31, 2001. Additional expense increases, which resulted from
our continued growth, were $0.2 million for depreciation, $0.2 million for telecommunications, $0.2
million for facilities rent and $0.6 million related to bad debts. We have also experienced increased
expenses of $0.7 million in professional fees, investor relations and directors’ fees, which resulted from
becoming a public company.
As a result of the foregoing factors, income before taxes increased by 44.8% or $3.9 million to
$12.6 million for 2002 from $8.7 million for 2001.
Liquidity and Capital Resources
As of March 10, 2004, we had $9.3 million in cash and cash equivalents. This cash reserve plus
cash generated from our normal operating activities should be adequate to fund our business for the
foreseeable future. Our principal source of liquidity has been cash provided by operating activities. Cash
provided by operating activities has been used primarily to fund the growth in our business and, prior to
our IPO, to pay S corporation distributions to our stockholders. We paid cash distributions to our pre-IPO
stockholders in the aggregate amounts of $0.3 million, $16.9 million and $6.6 million in 2003, 2002 and
2001, respectively. Because of our strong cash position, our board of directors decided to begin paying a
quarterly dividend in 2003, and we declared and paid dividends in the aggregate amount of $2.7 million.
We believe that paying dividends is an effective way of providing an investment return to our
stockholders and a beneficial use of our cash.
Net cash provided by operating activities totaled $8.0 million, $7.0 million and $9.0 million for
2003, 2002 and 2001, respectively. The decrease in cash provided by operating activities from 2001 to
2002 was primarily related to an increase in accounts receivable. In 2003, we experienced significant
improvement in our cash collections, which produced a meaningful increase in our cash from operating
activities. Upon the completion of our IPO, we converted from an S corporation to a C corporation for
tax purposes. As a result, some of our cash provided by our operating activities is now required to pay
taxes on our income.
29
Net cash used in investing activities totaled $2.0 million, $1.9 million and $1.3 million for 2003,
2002 and 2001, respectively. In each of those years we used cash for the purchase of property and
equipment.
Net cash used in financing activities totaled $2.9 million, $0.7 million and $6.7 million for 2003,
2002 and 2001, respectively. During 2003, we declared and paid dividends in the aggregate amount of
$2.7 million. We also made a final cash distribution to our pre-IPO stockholders in the amount of $0.3
million for previously taxed S corporation income. During 2002, we received $16.9 million as net
proceeds from our IPO. Prior to the IPO, we made cash distributions to our stockholders in the amount of
$2.6 million. From the IPO proceeds, we made additional cash distributions to our pre-IPO stockholders
in the amount of $14.3 million for previously taxed S corporation income. We also retired outstanding
long-term debt in the amount of $0.7 million. During 2001, we used cash primarily to pay cash
distributions to our stockholders.
Our days sales outstanding for the years 2003, 2002 and 2001 were 50.0, 56.8 and 41.7
respectively.
We currently do not have a bank line of credit or other credit facility in place. Because we have
no debt, we will not be subject to contractual restrictions or other influences on our operations, such as
payment demands and restrictions on the use of operating funds that are typically associated with debt. If
we borrow money in the future, we will likely be subject to operating and financial covenants that could
limit our ability to operate as profitably as we have in the past. Defaults under applicable loan agreements
could result in the demand by lenders for immediate payment of substantial funds and substantial
restrictions on expenditures, among other things.
Related Party Transactions
We lease the majority of our corporate headquarters campus from CP Investments, Inc., an
Alabama corporation, the stockholders of which are John Morrissey, John Heyer, Bob O'Donnell, Elissa
Stillings, Kevin P. Wilkins, Tabitha M. Wilkins Olzinski, Ellen M. Harvey, Michael K. Muscat, Jr. and
Susan M. Slaton. All of these individuals are either stockholders of CPSI, or, in the case of Ms. Stillings,
the spouse of a stockholder. In 2003, we paid total lease payments in the amount of $1,284,978 to CP
Investments, Inc. Under these lease agreements, we make annual lease payments in the amount of
$1,325,275, subject to adjustment as set forth in the agreements. The annual rent payable under these
leases has been determined by an independent, third-party appraisal firm. The parties may agree, from
time to time, to make adjustments in the annual rent payable under these leases based on subsequent third-
party appraisals.
We lease the remainder of our headquarters facilities, which is comprised of one building that
houses our dedicated research and development staff, from DJK, LLC, a limited liability company owned
by Dennis Wilkins. In 2003, we paid total lease payments in the amount of $39,747 to DJK, LLC. The
annual rent payable under this lease has been determined by an independent, third-party appraisal firm.
30
Contractual Obligations
Our related party real estate leases are our only material contractual obligations requiring
recurring payments in the future. Our payments under these leases subsequent to December 31, 2003 will
be as follows:
Contractual Obligations
Total
Payments due by period
Less than
1 year
1-3 years
3-5 years
More than
5 years
Operating Lease
Obligations
$11,431,525
$1,365,275
$2,730,550
$2,730,550
$4,605,150
Off-Balance Sheet Arrangements
We are not currently a party to any material “off-balance sheet arrangement” as defined in Item 303
of Regulation S-K.
Critical Accounting Policies
General. Our discussion and analysis of our financial condition and results of operations are
based on our financial statements, which have been prepared in accordance with generally accepted
accounting principles. We are required to make some estimates and judgments that affect the preparation
of these financial statements. We base our estimates on historical experience and on various other
assumptions that we believe to be reasonable under the circumstances, but actual results may differ from
these estimates under different assumptions or conditions.
Revenue Recognition. We recognize revenue in accordance with SEC Staff Accounting Bulletin
No. 101 (SAB 101), Revenue Recognition in Financial Statements, as amended by SAB 101A and 101B
and the American Institute of Certified Public Accountants Statement of Position (SOP) 97-2, Software
Revenue Recognition. SAB 101 and SOP 97-2 require that four basic criteria must be met before
revenues can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred
or services have been rendered; (3) the fee is fixed and determinable; and (4) collectibility is reasonably
assured. Determination of criteria (3) and (4) are based on our judgment regarding the fixed nature of the
fee charged for services rendered and products delivered and the collectibility of those fees. Should
changes in conditions cause us to determine these criteria are not met for certain future transactions,
revenues recognized for any reporting period could be adversely affected.
Backlog
Backlog consists of revenues we reasonably expect to recognize over the next twelve months
under existing contracts. The revenues to be recognized may relate to a combination of one-time fees for
system sales, and recurring fees for support, outsourcing, ASP and ISP services. As of December 31,
2003, we had a twelve-month backlog of approximately $15.8 million in connection with non-recurring
system purchases and approximately $44.9 million in connection with recurring payments under support,
outsourcing, ASP and ISP contracts.
Quantitative and Qualitative Disclosures about Market and Interest Rate Risk
We reduce the sensitivity of our results of operations to market risks related to changes in interest
rates by maintaining an investment portfolio comprised solely of highly rated, short-term investments. We
do not hold or issue derivative, derivative commodity instruments or other financial instruments for
31
trading purposes. We are not exposed to currency exchange fluctuations, as we do not sell our products
internationally, and we currently have no exposure to equity price risks.
Recent Accounting Pronouncements
In June 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations.
SFAS No. 143 addresses financial accounting and reporting for obligations associated with the retirement
of tangible long-lived assets and the associated asset retirement costs. It applies to legal obligations
associated with the retirement of long-lived assets that result from the acquisition, construction,
development and/or the normal operation of a long-lived asset, except for certain obligations of lessees.
The adoption of this standard in 2003 did not have any effect on the Company’s financial position, results
of operations or cash flows.
In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets. SFAS No. 144 addresses financial accounting and reporting for the impairment or
disposal of long-lived assets. The adoption of this standard in 2002 did not have any effect on the
Company’s financial position, results of operations or cash flows.
In July 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or
Disposal Activities. SFAS No. 146 addresses significant issues regarding the recognition, measurement
and reporting of costs that are associated with exit and disposal activities, including restructuring
activities that are currently accounted for pursuant to the guidance set forth in EITF No. 94-3, Liability
Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. SFAS No.
146 revises the accounting for certain lease termination costs and employee termination benefits, which
are generally recognized in connection with restructuring activities. Adoption of this standard in 2003 did
not have any effect on the Company’s financial position, results of operations or cash flows.
On December 31, 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based
Compensation—Transition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-
Based Compensation, to provide alternative methods of transition to SFAS No. 123’s fair value method of
accounting for stock-based employee compensation. SFAS No. 148 also amends the disclosure provisions
of SFAS No. 123 and APB Opinion No. 28, Interim Financial Reporting, to require disclosure in the
summary of significant accounting policies of the effect’s of an entity’s accounting policy with respect to
stock-based compensation. While the Statement does not amend SFAS No. 123 to require companies to
account for employee stock options using the fair value method, the disclosure provisions of SFAS No.
148 are applicable to all companies with stock-based employee compensation, regardless of whether they
account for that compensation using the fair value method of SFAS No. 123 or the intrinsic value method
of Opinion 25. The Company adopted the disclosure requirement of this standard in 2002.
In January 2003, the FASB issued Interpretation 46 (FIN46), Consolidation of Variable Interest
Entities. In general, a variable interest entity is a corporation, partnership, trust, or any other legal
structure used for business purposes that either (a) does not have equity investors with voting rights or (b)
has equity investors that do not provide sufficient financial resources for the entity to support its
activities. FIN 46 requires a variable interest entity to be consolidated by a company if that company is
subject to a majority of the risk of loss from the variable interest entity's activities or entitled to receive a
majority of the entity's residual returns or both. The consolidation requirements of FIN 46 apply
immediately to variable interest entities created after January 31, 2003. The consolidation requirements
apply to transactions entered into prior to February 1, 2003 in the first fiscal year or interim period
beginning after June 15, 2003. Certain of the disclosure requirements apply in all financial statements
32
issued after January 31, 2003, regardless of when the variable interest entity was established. The
adoption of FIN 46 on July 1, 2003 did not have an impact on our financial statements.
In December 2003, the FASB issued Interpretation 46R (FIN 46R), a revision to FIN 46,
Consolidation of Variable Interest Entities. FIN 46R clarifies some of the provisions of FIN 46 and
exempts certain entities from its requirements. FIN 46R is effective at the end of the first interim period
ending after March 15, 2004. Entities that have adopted FIN 46 prior to this effective date can continue to
apply the provisions of FIN 46 until the effective date of FIN 46R. As noted above, CPSI adopted FIN 46
on July 1, 2003 and it did not have an impact on our financial statements. The early adoption of FIN 46R
did not have an impact on our financial statements.
In April 2003, the FASB issued SFAS 149, Amendment of Statement 133 on Derivative
Instruments and Hedging Activities, which amends and clarifies accounting for derivative instruments,
including certain derivative instruments embedded in other contracts, and for hedging activities under
SFAS 133. The statement is effective (with certain exceptions) for contracts entered into or modified after
June 30, 2003. This statement will not have an impact on our financial statements.
In May 2003, the FASB issued SFAS 150, Accounting for Certain Financial Instruments with
Characteristics of both Liabilities and Equity. The statement establishes standards for how an issuer
classifies and measures certain financial instruments with characteristics of both liabilities and equity. It
requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in
some circumstances). It is effective for financial instruments entered into or modified after May 31, 2003,
and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. This
statement will not have an impact on our financial statements.
RISK FACTORS
Market factors may cause a decline in spending for information technology and services by our
current and prospective customers which may result in less demand for our products, lower prices
and, consequently, lower revenues and a lower revenue growth rate.
The purchase of our information system involves a significant financial commitment by our
customers. At the same time, the healthcare industry faces significant financial pressures that could
adversely affect overall spending on healthcare information technology and services. For example, the
Balanced Budget Act of 1997 has significantly reduced Medicare reimbursements to hospitals, leaving
them less money to invest in infrastructure. Moreover, a general economic decline could cause hospitals
to reduce or eliminate information technology related spending. To the extent spending for healthcare
information technology and services declines or increases slower than we anticipate, demand for our
products and services, as well as the prices we charge, could be adversely affected. Accordingly, we
cannot assure you that we will be able to increase or maintain our revenues or our growth rate.
There are a limited number of hospitals in our target market. Continued consolidation in the
healthcare industry could result in the loss of existing customers, a reduction in our potential
customer base and downward pressure on our products' prices.
There are a finite number of small and midsize hospitals with 300 or fewer acute care beds.
Saturation of this market with our products or our competitors' products could eventually limit our
revenues and growth. Furthermore, many healthcare providers have consolidated to create larger
healthcare delivery enterprises with greater market power. If this consolidation continues, we could lose
existing customers and could experience a decrease in the number of potential purchasers of our products
and services. The loss of existing and potential customers due to industry consolidation could cause our
33
revenue growth rate to decline. In addition, larger, consolidated enterprises could have greater bargaining
power, which may lead to downward pressure on the prices for our products and services.
We may experience fluctuations in quarterly financial performance that cause us to fail to meet
revenues or earnings expectations. Failure to meet these expectations could adversely impact our
stock price.
There is no assurance that consistent quarterly growth in our business will continue. Our quarterly
revenues may fluctuate and may be difficult to forecast for a variety of reasons. For example, prospective
customers often take significant time evaluating our system and related services before making a purchase
decision. Moreover, a prospective customer who has placed an order for our system could decide to
cancel that order or postpone installation of the ordered system. If a prospective customer delays or
cancels a scheduled system installation during any quarter, we may not be able to schedule a substitute
system installation during that quarter. The amount of revenues that would have been generated from that
installation will be postponed or lost. The possibility of delays or cancellations of scheduled system
installations could cause our quarterly revenues to fluctuate.
The following factors may also affect demand for our products and services and cause our
quarterly revenues to fluctuate:
•
•
•
•
changes in customer budgets and purchasing priorities;
market acceptance of new products, product enhancements and services from us
and our competitors;
product and price competition; and
delay of revenue recognition to future quarters due to an increase in the sale of
our remote access ASP services.
Variations in our quarterly revenues may adversely affect our operating results. In each fiscal
quarter, our expense levels, operating costs and hiring plans are based on projections of future revenues
and are relatively fixed. If our actual revenues fall below expectations, our earnings will also likely fail to
meet expectations. If we fail to meet the revenue or earnings expectations of securities analysts and
investors, then the price of our common stock will likely decrease.
Competition with companies that have greater financial, technical and marketing resources than
we have could result in loss of customers and/or a lowering of prices for our products, causing a
decrease in our revenues and/or market share.
Our principal competitors are Meditech and HMS. Meditech and HMS compete with us directly
in our target market of small and midsize hospitals. These companies offer products and services that are
comparable to our system and are designed to address the needs of community hospitals.
Our secondary competitors include McKesson Corporation, Quadramed Corp., Cerner
Corporation, and Siemens Corporation. These companies are significantly larger than we are, and they
typically sell their products and services to larger hospitals outside of our target market. However, they
sometimes compete directly with us. We also face competition from providers of practice management
systems, general decision support and database systems and other segment-specific applications, as well
as from healthcare technology consultants. Any of these companies as well as other technology or
healthcare companies could decide at any time to specifically target hospitals within our target market.
A number of existing and potential competitors are more established than we are and have greater
name recognition and financial, technical and marketing resources. Products of our competitors may have
34
better performance, lower prices and broader market acceptance than our products. We expect increased
competition that could cause us to lose customers, lower our prices to remain competitive and experience
lower revenues, revenue growth and profit margins.
Our failure to develop new products or enhance current products in response to market demands
could adversely impact our competitive position and require substantial capital resources to
correct.
The needs of hospitals in our target market are subject to rapid change due to government
regulation, trends in clinical care practices and technological advancements. As a result of these changes,
our products may quickly become obsolete or less competitive. New product introductions and
enhancements by our competitors that more effectively or timely respond to changing industry needs may
weaken our competitive position.
We continually redesign and enhance our products to incorporate new technologies and adapt our
products to ever-changing hardware and software platforms. Often we face difficult choices regarding
which new technologies to adopt. If we fail to anticipate or respond adequately to technological
advancements, or experience significant delays in product development or introduction, our competitive
position could be negatively affected. Moreover, our failure to offer products acceptable to our target
market could require us to make significant capital investments and incur higher operating costs to
redesign our products, which could negatively affect our financial condition and operating results.
Potential regulation of our products as medical devices by the U.S. Food and Drug Administration
could increase our costs, delay the introduction of new products and slow our revenue growth.
The U.S. Food and Drug Administration, or the "FDA," is likely to become more active in regulating
the use of computer software for clinical purposes. The FDA has increasingly regulated computer products
and computer-assisted products as medical devices under the federal Food, Drug and Cosmetic Act. If the
FDA regulates any of our products as medical devices, we would likely be required to, among other things:
•
•
•
seek FDA clearance by demonstrating that our product is substantially equivalent
to a device already legally marketed, or obtain FDA approval by establishing the
safety and effectiveness of our product;
comply with rigorous regulations governing pre-clinical and clinical testing,
manufacture, distribution, labeling and promotion of medical devices; and
comply with the Food, Drug and Cosmetic Act's general controls, including
establishment registration, device listing, compliance with good manufacturing
practices and reporting of specified device malfunctions and other adverse device
events.
We anticipate that some of our products currently in development will be subject to FDA
regulation. If any of our products fail to comply with FDA requirements, we could face FDA refusal to
grant pre-market clearance or approval of products; withdrawal of existing clearances and approvals;
fines, injunctions or civil penalties; recalls or product corrections; production suspensions; and criminal
prosecution. FDA regulation of our products could increase our operating costs, delay or prevent the
marketing of new or existing products and adversely affect our revenue growth.
35
Governmental regulations relating to patient confidentiality and other matters could increase our
costs.
State and federal laws regulate the confidentiality of patient records and the circumstances under
which those records may be released. These regulations may require the users of such information to
implement security measures. Regulations governing electronic health data transmissions are also
evolving rapidly, and they are often unclear and difficult to apply.
The Health Insurance Portability and Accountability Act of 1996, or "HIPAA," requires, among
other things, the Secretary of Health and Human Services, or "HHS," to adopt national standards to
ensure the integrity and confidentiality of health information. HHS’s health data privacy regulations
restrict the use and disclosure of personally identifiable health information without the prior informed
consent of the patient. In addition, HHS has also issued final regulations establishing national standards
for some healthcare-related electronic transactions and uniform code sets to be used in those transactions.
Although these regulations were to be effective in October 2003, CMS is currently allowing providers and
payers to continue utilizing non-compliant transaction code sets. The length of this grace period has not
yet been determined. In February 2003, HHS issued final rules with respect to information security that
would require healthcare providers to implement organizational practices to protect the security of
electronically maintained or transmitted health-related information, such as the use of electronic
signatures and single sign-on access to information. Customers must be in compliance with these new
regulations by April 2005. HHS has also provided a final rule for employer identifiers; however no other
rules, proposed or final, have yet been issued with respect to unique health identifiers for providers or
patients. We cannot predict the potential impact of proposed rules and rules that have not yet been
proposed. In addition to HIPAA, other federal and/or state privacy legislation may be enacted at any time.
In our support agreements with our customers, we agree to update our software applications to
comply with applicable federal and state laws. While we believe we have developed products that will
comply with current HIPAA and other regulatory requirements, new laws, regulations and interpretations
could force us to further redesign our products. Any such product redesign could consume significant
capital, research and development and other resources, which could significantly increase our operating
costs.
Our products assist clinical decision-making and related care by capturing, maintaining and
reporting relevant patient data. If our products fail to provide accurate and timely information, our
customers could assert claims against us that could result in substantial cost to us, harm our
reputation in the industry and cause demand for our products to decline.
We provide products that assist clinical decision-making and related care by capturing,
maintaining and reporting relevant patient data. Our products could fail or produce inaccurate results due
to a variety of reasons, including mechanical error, product flaws, faulty installation and/or human error
during the initial data conversion. If our products fail to provide accurate and timely information,
customers and/or patients could sue us to hold us responsible for losses they incur from these errors.
These lawsuits, regardless of merit or outcome, could result in substantial cost to us, divert management's
attention from operations and decrease market acceptance of our products. We attempt to limit by contract
our liability for damages arising from negligence, errors or mistakes. Despite this precaution, such
contract provisions may not be enforceable or may not otherwise protect us from liability for damages.
We maintain general liability insurance coverage, including coverage for errors or omissions. However,
this coverage may not be sufficient to cover one or more large claims against us or otherwise continue to
be available on terms acceptable to us. In addition, the insurer could disclaim coverage as to any future
claim.
36
Breaches of security in our system could result in customer claims against us and harm to our
reputation causing us to incur expenses and/or lose customers.
We have included security features in our systems that are intended to protect the privacy and
integrity of patient data. Despite the existence of these security features, our system may experience
break-ins and similar disruptive problems that could jeopardize the security of information stored in and
transmitted through the computer networks of our customers. Because of the sensitivity of medical
information, customers could sue us for breaches of security involving our system. Also, actual or
perceived security breaches in our system could harm the market perception of our products which could
cause us to lose existing and prospective customers.
New products that we introduce or enhancements to our existing products may contain undetected
errors or problems that could affect customer satisfaction and cause a decrease in revenues.
Highly complex software products such as ours sometimes contain undetected errors or failures
when first introduced or when updates and new versions are released. Tests of our products may not
detect bugs or errors because it is difficult to simulate our customers' wide variety of computing
environments. Despite extensive testing, from time to time we have discovered defects or errors in our
products. Defects or errors discovered in our products could cause delays in product introductions and
shipments, result in increased costs and diversion of development resources, require design modifications,
decrease market acceptance or customer satisfaction with our products, cause a loss of revenue, result in
legal actions by our customers and cause increased insurance costs.
Our facilities are located in an area vulnerable to hurricanes and tropical storms, and the
occurrence of a severe hurricane, similar storm or other natural disaster could cause damage to our
facilities and equipment, which could require us to cease or limit our operations.
All of our facilities and virtually all of our employees are situated on one campus in Mobile,
Alabama, which is located on the coast of the Gulf of Mexico. Our facilities are vulnerable to significant
damage or destruction from hurricanes and tropical storms. We are also vulnerable to damage from other
types of disasters, including tornadoes, fires, floods and similar events. If any disaster were to occur, our
ability to conduct business at our facilities could be seriously impaired or completely destroyed. This
would have adverse consequences for our customers who depend on us for system support or outsourcing
services. Also, the servers of customers who use our remote access services could be damaged or
destroyed in any such disaster. This would have potentially devastating consequences to those customers.
Although we have an emergency recovery plan, there can be no assurance that this plan will effectively
prevent the interruption of our business due to a natural disaster. Furthermore, the insurance we maintain
may not be adequate to cover our losses resulting from any natural disaster or other business interruption.
Interruptions in our power supply and/or telecommunications capabilities could disrupt our
operations, cause us to lose revenues and/or increase our expenses.
We currently have backup generators to be used as alternative sources of power in the event of a
loss of power to our facilities. If these generators were to fail during any power outage, we would be
temporarily unable to continue operations at our facilities. This would have adverse consequences for our
customers who depend on us for system support and outsourcing services. Any such interruption in
operations at our facilities could damage our reputation, harm our ability to retain existing customers and
obtain new customers, and could result in lost revenue and increased insurance and other operating costs.
We also have customers for whom we store and maintain computer servers containing critical
patient and administrative data. Those customers access this data remotely through telecommunications
37
lines. If our power generators fail during any power outage or if our telecommunications lines are severed
or impaired for any reason, those customers would be unable to access their mission critical data causing
an interruption in their operations. In such event our remote access customers and/or their patients could
seek to hold us responsible for any losses. We would also potentially lose those customers, and our
reputation could be harmed.
If we are unable to attract and retain qualified customer service and support personnel our
business and operating results will suffer.
Our customer service and support is a key component of our business. Most of our hospital
customers have small information technology staffs, and they depend on us to service and support their
systems. Future difficulty in attracting, training and retaining capable customer service and support
personnel could cause a decrease in the overall quality of our customer service and support. That decrease
would have a negative effect on customer satisfaction which could cause us to lose existing customers and
could have an adverse effect on our new customer sales. The loss of customers due to inadequate
customer service and support would negatively impact our ability to continue to grow our business.
We do not have employment or non-competition agreements with our key personnel, and their
departure could harm our future success.
Our future success depends to a significant extent on the leadership and performance of our chief
executive officer, chief operating officer and other executive officers. We do not have employment or
non-competition agreements with any of our executive officers. Therefore, they may terminate their
employment with us at any time and may compete against us. The loss of the services of any of our
executive officers could have a material adverse effect on our business, financial condition and results of
operations.
We have limited protection of our intellectual property and, if we fail to adequately protect our
intellectual property, we may not be able to compete effectively.
We consider some aspects of our internal operations, products and documentation to be
proprietary. To some extent we have relied on a combination of confidentiality provisions in our customer
agreements, copyright, trademark and trade secret laws and other measures to protect our intellectual
property. To date, however, we have not filed any patent applications to protect our proprietary software
products. In addition, existing copyright laws afford only limited protection. Although we attempt to
control access to our intellectual property, unauthorized persons may attempt to copy or otherwise use our
intellectual property. Monitoring unauthorized use of our intellectual property is difficult, and the steps
we have taken may not prevent unauthorized use. If our competitors gain access to our intellectual
property, our competitive position in the industry could be damaged. An inability to compete effectively
could cause us to lose existing and potential customers and experience lower revenues, revenue growth
and profit margins.
In the event our products infringe on the intellectual property rights of third-parties, our business
may suffer if we are sued for infringement or if we cannot obtain licenses to these rights on
commercially acceptable terms.
Others may sue us alleging infringement of their intellectual property rights. Many participants in
the technology industry have an increasing number of patents and patent applications and have frequently
demonstrated a readiness to take legal action based on allegations of patent and other intellectual property
infringement. Further, as the number and functionality of our products increase, we believe we may
become increasingly subject to the risk of infringement claims. If infringement claims are brought against
38
us, these assertions could distract management. We may have to spend a significant amount of money and
time to defend or settle those claims. If we were found to infringe on the intellectual property rights of
others, we could be forced to pay significant license fees or damages for infringement. If we were unable
to obtain licenses to these rights on commercially acceptable terms, we would be required to discontinue
the sale of our products that contain the infringing technology. Our customers would also be required to
discontinue the use of those products. We are unable to insure against this risk on an economically
feasible basis. Even if we were to prevail in an infringement lawsuit, the accompanying publicity could
adversely impact the demand for our system. Under some circumstances, we agree to indemnify our
customers for some types of infringement claims that may arise from the use of our products.
ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
The information required by this item is contained in Item 7 herein under the heading
"Quantitative and Qualitative Disclosures about Market and Interest Rate Risk."
ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Index to Financial Statements:
Financial Statements:
Report of Ernst & Young LLP, Independent Auditors
Balance Sheets – December 31, 2003 and 2002
Statements of Income – Years ended December 31, 2003, 2002 and 2001
Statements of Stockholders' Equity – Years ended December 31, 2003, 2002 and
2001
Statements of Cash Flows – Years ended December 31, 2003, 2002 and 2001
Notes to Financial Statements
Financial Statement Schedules:
Schedule II – Valuation of Qualifying Accounts for each of the three years in the
period ended December 31, 2003
All other schedules to the financial statements required by Article 9 of
Regulation S-X are inapplicable and therefore have been omitted.
39
REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
The Board of Directors
Computer Programs and Systems, Inc.
We have audited the accompanying balance sheets of Computer Programs and Systems, Inc. as of
December 31, 2003 and 2002, and the related statements of income, stockholders’ equity and cash flows
for each of the three years in the period ended December 31, 2003. Our audits also included the financial
statement schedule listed in the index at Item 8. These financial statements and schedule are the
responsibility of the Company’s management. Our responsibility is to express an opinion on these
financial statements and schedule based on our audits.
We conducted our audits in accordance with auditing standards generally accepted in the United States.
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our audits provide a reasonable
basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the
financial position of Computer Programs and Systems, Inc. at December 31, 2003 and 2002, and the
results of its operations and its cash flows for each of the three years in the period ended December 31,
2003, in conformity with accounting principles generally accepted in the United States. Also, in our
opinion, the related financial statement schedule, when considered in relation to the financial statements
taken as a whole, presents fairly in all material respects the information set forth therein.
/s/ Ernst & Young LLP
February 3, 2004
Birmingham, Alabama
40
COMPUTER PROGRAMS AND SYSTEMS, INC.
Balance Sheets
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowance for doubtful accounts
of $904,000 and $768,000, respectively
Financing receivables, current portion
Inventories
Deferred tax assets
Prepaid income taxes
Prepaid expenses
Total current assets
Property and equipment
Land
Maintenance equipment
Computer equipment
Office furniture and equipment
Automobiles
Less accumulated depreciation
Net property and equipment
Financing receivables
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Deferred revenue
Sales, income and use taxes payable
Accrued vacation
Other accrued liabilities
Income taxes payable
Total current liabilities
Stockholders' equity:
Common stock, $0.001 par value; 30,000,000 shares authorized;
10,489,849 and 10,488,000 shares issued and outstanding
Additional paid-in capital
Deferred compensation
Retained earnings
Total stockholders' equity
Total liabilities and stockholders' equity
See accompanying notes.
41
December 31,
2003
December 31,
2002
$ 9,472,743
$ 6,352,452
11,916,414
1,112,773
1,102,061
973,173
120,025
364,384
12,598,511
1,341,047
1,615,312
1,006,470
-
327,533
25,061,573
23,241,325
936,026
3,172,303
4,320,011
1,391,110
89,934
9,909,384
(4,561,080)
936,026
2,679,766
3,486,030
1,023,771
89,934
8,215,527
(3,388,704)
5,348,304
793,870
4,826,823
840,603
$ 31,203,747
$ 28,908,751
$ 1,126,334
1,633,887
38,697
1,561,577
1,091,279
-
$ 2,093,812
2,347,816
1,258,553
1,317,247
1,218,741
193,546
5,451,774
8,429,715
10,490
17,289,910
(174,385)
8,625,958
10,488
17,259,403
(225,423)
3,434,568
25,751,973
20,479,036
$ 31,203,747
$ 28,908,751
COMPUTER PROGRAMS AND SYSTEMS, INC.
Statements of Income
Sales revenues:
System sales
Support and maintenance
Outsourcing
Total sales revenues
Costs of sales:
System sales
Support and maintenance
Outsourcing
Total costs of sales
Gross profit
Operating expenses:
Sales and marketing
General and administrative
Total operating expenses
Operating income
Other income (expense):
Interest income
Miscellaneous income
Interest expense
Total other income
2003
Year ended December 31,
2002
2001
$ 39,707,684
34,567,017
7,028,159
81,302,860
$ 38,309,227
30,246,030
5,188,963
73,744,220
$ 30,350,201
25,822,575
3,493,629
59,666,405
28,045,002
16,100,525
4,258,778
48,404,305
32,898,555
25,837,901
13,905,072
3,182,430
42,925,403
30,818,817
22,498,667
11,634,448
2,108,672
36,241,787
23,424,618
6,125,437
14,227,439
20,352,876
12,545,679
5,933,472
12,816,785
18,750,257
12,068,560
5,104,906
9,843,543
14,948,449
8,476,169
216,001
121,797
-
337,798
214,044
361,682
(23,677)
552,049
125,881
153,892
(75,742)
204,031
Income before taxes
12,883,477
12,620,609
8,680,200
Income taxes
Net income
5,017,647
1,970,816
-
$ 7,865,830
$ 10,649,793
$ 8,680,200
Net income per share - basic
$ 0.75
$ 1.06
$ 0.93
Net income per share - diluted
$ 0.75
$ 1.06
$ 0.93
Weighted average shares outstanding
Basic
Diluted
Unaudited pro forma income data:
Historical income before provision for income taxes
Pro forma income taxes
Pro forma net income
Pro forma net income per share – basic
Pro forma net income per share – diluted
See accompanying notes.
42
10,488,406
10,536,929
10,024,438
10,061,765
9,288,000
9,288,000
$ 12,620,609
4,576,654
$ 8,043,955
$ 8,680,200
3,231,501
$ 5,448,699
$ 0.80
$ 0.59
$ 0.80
$ 0.59
COMPUTER PROGRAMS AND SYSTEMS, INC.
Statements of Stockholders’ Equity
Common
Shares
Common
Stock
Additional
Paid-in
Capital
Deferred
Compensation
Retained
Earnings
Total
Stockholders'
Equity
Balance at December 31, 2000
9,288,000 $ 9,288 $ 109,811 $ - $ 7,837,083 $ 7,956,182
Net income
Distributions to S corporation
shareholders
- - -
- - -
- 8,680,200
8,680,200
- (6,600,000) (6,600,000)
Balance at December 31, 2001
9,288,000 9,288 109,811 - 9,917,283
10,036,382
Net income
Issuance of common stock
Deferred compensation
Amortization of deferred compensation
Distributions to S corporation
shareholders
10,649,793
- 10,649,793
- - -
16,895,596
-
1,200,000 1,200 16,894,396 -
-
-
255,196 (255,196)
- -
29,773
- - -
29,773
-
- (17,132,508) (17,132,508)
- - -
Balance at December 31, 2002
10,488,000 10,488 17,259,403 (225,423) 3,434,568
20,479,036
Net income
Issuance of common stock
Dividends
Amortization of deferred compensation
- - -
1,849 2 30,507 -
- - -
- - -
7,865,830
- 7,865,830
30,509
-
- (2,674,440) (2,674,440)
51,038
-
51,038
Balance at December 31, 2003
10,489,849 $ 10,490 $ 17,289,910 $ (174,385) $ 8,625,958 $ 25,751,973
See accompanying notes.
43
COMPUTER PROGRAMS AND SYSTEMS, INC.
Statements of Cash Flows
Operating Activities
Net income
Adjustments to net income:
Provision for bad debt
Deferred taxes
Deferred compensation
Depreciation
Changes in operating assets and liabilities:
Accounts receivable
Financing receivables
Inventories
Prepaid expenses
Accounts payable
Deferred revenue
Sales, income and use taxes payable
Other liabilities
Income taxes payable
Year ended December 31,
2003
2002
2001
$ 7,865,830
$ 10,649,793
$ 8,680,200
256,790
33,297
51,038
1,461,039
818,327
(1,006,470)
29,773
1,128,454
225,236
-
-
954,543
425,307
275,007
513,251
(36,851)
(967,478)
(713,929)
(1,219,856)
366,868
(313,571)
(5,309,371)
(413,430)
(488,959)
(131,257)
1,060,463
746,686
(621,386)
335,199
193,546
(580,347)
(1,129,187)
3,839
96,641
(207,049)
186,926
486,335
269,865
-
Net cash provided by operating activities
7,996,742
6,991,368
8,987,002
Investing Activities
Purchases of property and equipment
(1,982,520)
(1,920,750)
(1,321,948)
Net cash used in investing activities
(1,982,520)
(1,920,750)
(1,321,948)
Financing Activities
Proceeds from issuance of common stock, net of expenses
Principal payments on note payable
Dividends paid
Distributions to S corporation shareholders
30,509
-
(2,674,440)
(250,000)
16,895,596
(749,897)
-
(16,882,508)
-
(79,559)
-
(6,600,000)
Net cash used in financing activities
(2,893,931)
(736,809)
(6,679,559)
Increase in cash and cash equivalents
3,120,291
4,333,809
985,495
Cash and cash equivalents at beginning of year
6,352,452
2,018,643
1,033,148
Cash and cash equivalents at end of year
$ 9,472,743
$ 6,352,452
$ 2,018,643
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
$ -
5,331,218
$ 23,677
2,783,740
$ 75,742
-
See accompanying notes.
44
COMPUTER PROGRAMS AND SYSTEMS, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2003
1. BASIS OF PRESENTATION
Computer Programs and Systems, Inc. (CPSI or the Company) is a healthcare information technology
solutions provider which was formed and commenced operations in 1979. The Company provides, on an
integrated basis, enterprise-wide clinical management, access management, patient financial management,
health information management, strategic decision support, resource planning management and enterprise
application integration solutions to healthcare organizations throughout the United States. Additionally,
CPSI provides other information technology solutions including outsourcing, remote hosting, networking
technologies and other related services.
2. PUBLIC OFFERING OF COMMON STOCK AND RECAPITALIZATION
On May 24, 2002, the Company successfully completed an initial public offering of 3.0 million shares of
common stock at a price of $16.50 per share. Of the shares offered, 1.2 million shares were sold by the
Company and 1.8 million shares were sold by selling stockholders. In addition, the underwriters for the
Company exercised their over-allotment option by purchasing an additional 450,000 shares at $16.50 per
share from selling stockholders. Of the net proceeds to the Company of approximately $16.9 million,
approximately $14.3 million was used to fund a partial distribution to pre-IPO stockholders of previously
taxed S corporation income, and the balance was used to repay outstanding debt and for general corporate
purposes.
On May 1, 2002, the Company declared a 430-for-1 stock split, and on May 6, 2002, the Company
amended its Articles of Incorporation to increase the Company’s total authorized shares to 10,000,000
and to change the par value to $0.001 per share. All share and per share amounts for all periods presented
in the accompanying financial statements have been restated to reflect the split.
Effective immediately prior to the completion of the offering, the Company reincorporated in Delaware.
As a Delaware corporation, the Company now has 30,000,000 shares of authorized common stock with a
par value per share of $0.001.
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash and Cash Equivalents
Cash and cash equivalents consists of highly-liquid financial instruments, primarily cash and money
market funds, purchased with an original maturity of three months or less.
Inventories
Inventories are stated at cost using the average cost method. The Company’s inventories are composed of
computer equipment, forms and supplies.
45
Property and Equipment
Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements
to property and equipment that materially increase productive capacity or extend the life of an asset are
capitalized. Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other
disposition of such assets, the related costs and accumulated depreciation are removed from the respective
accounts and any resulting gain or loss is included in the results of operations.
Depreciation expense is computed using the straight-line method over the asset’s useful life, generally 5
years. The Company reviews for the possible impairment of long-lived assets whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable.
Deferred Revenue
Deferred revenue represents amounts received from customers under licensing agreements and
implementation fees for which the revenue earnings process has not been completed.
Revenue Recognition
Systems sales revenues are derived from the sale of information systems (including software, conversion
and installation services, hardware, peripherals, forms and office supplies) to new customers and from the
sale of new or additional products to existing customers. The Company recognizes revenue from systems
sales on a completed contract basis in accordance with American Institute of Certified Public Accountants
Statement of Position (SOP) 97-2, Software Revenue Recognition, and SOP 81-1, Accounting for
Performance of Construction Type and Certain Production-Type Contracts. A contract is regarded as
substantially complete when all hardware and software is installed and the system is operating as
intended. Losses are recorded for the entire estimated loss on the contract in the period that it becomes
evident that current estimates of total contract revenue and contract costs indicate a loss.
The Company does not record revenue upon execution of a sales contract. Each customer initially remits
a non-refundable 10% deposit that is recorded as deferred revenue. The customer then pays 40% of the
purchase price when the Company commences training on-site at the customer’s facility. When the
system becomes operational, the Company bills the remaining 50% of the system purchase price and
recognizes revenue for the total amount of the purchase price. Costs relating to system sales revenues are
deferred and recognized at the time the related revenues are recognized; however, at December 31, 2003
and 2002, no system sales-related costs were deferred as all contracts were deemed to be substantially
complete, or such amounts were not considered to be material. Revenues derived from installation of
additional software applications are generally recognized upon installation. Revenues from the sale of
hardware are recognized upon the shipment of the product to the customer.
The Company also derives revenues from the provision of system support services, including software
application support, hardware maintenance, continuing education and related services. Support services
are provided pursuant to a General Support Agreement under which the Company provides
comprehensive system support and related services in exchange for a monthly fee based on the services
provided. These contracts range in duration from 1 to 7 years, with an average duration of 5 years, and
renew automatically unless terminated by the customer. Revenues from support services are recognized
in the month when these services are performed.
As part of system sales, the Company also provides services to some customers as an application service
provider (ASP) for a monthly fee. In addition, the Company offers Internet services (ISP) to customers
46
for a monthly fee. Revenues from ASP and ISP services are recognized in the month when these services
are performed.
Outsourcing services are sold pursuant to one-year customer agreements, with automatic one-year
renewals. Revenues from outsourcing services are recognized when services are performed.
Stock Based Compensation
During 2002, the Company adopted the 2002 Stock Option Plan, and in accordance with the disclosure
provisions of SFAS No. 123, Accounting for Stock-Based Compensation, the Company has elected to
follow APB No. 25, Accounting for Stock Issued to Employees and related interpretations in accounting
for employee stock options. Under APB No. 25, because the exercise price of the Company’s employee
stock options equals the market price of the underlying stock on the date of grant, no compensation
expense was reflected in net income for the year ended December 31, 2003 or 2002. Had the Company
accounted for its stock-based compensation plan based on the fair value of awards at grant date,
consistent with the methodology of SFAS No. 123, the Company’s reported net income and income per
share for the years ended December 31, 2003 and 2002 would have been impacted as indicated below.
There were no employee stock options granted during the year ended December 31, 2003. The effects of
applying SFAS No. 123 on a pro forma basis for the year ended December 31, 2003, are not likely to be
representative of the effects on reported pro forma net income for future years as options vest over several
years and it is anticipated that additional grants will be made in future years.
Net income as reported
Deduct: Total stock-based employee
compensation expense determined under the
fair value method for all awards
December 31,
2003
2002
$7,865,830
$10,649,793
(192,168)
(117,436)
Pro forma net income
$7,673,662
$10,532,357
Diluted income per share as reported
Pro forma diluted income per share
$0.75
$0.73
$1.06
$1.05
Research and Development Costs
Research and development costs are expensed as incurred. Research and development costs totaled
approximately $1,143,000, $1,104,000 and $888,000 for the years ended December 31, 2003, 2002 and
2001, respectively.
Software Development Costs
According to Statement of Financial Accounting Standards (SFAS) No. 86, Accounting for the Costs of
Computer Software to be Sold, Leased or Otherwise Marketed, all costs incurred to establish the
technological feasibility of a computer software product to be sold, leased or otherwise marketed are
research and development costs and are charged to expense during the period when the costs are incurred.
Costs incurred subsequent to establishing technological feasibility are capitalized. Capitalization of
computer software costs ceases when the product is available for general release to customers. The
47
Company has determined that costs to be capitalized based on SFAS No. 86 are not material. Software
and development costs of approximately $189,000, $104,000 and $168,000 were charged to expense
during the years ended December 31, 2003, 2002 and 2001, respectively.
Advertising
Advertising costs are expensed as incurred. Advertising expense was approximately $307,000, $373,000
and $377,000 for the years ended December 31, 2003, 2002 and 2001, respectively.
Shipping and Handling Costs
Shipping and handling costs are expensed as incurred. Shipping and handling costs totaled approximately
$764,000, $664,000 and $377,000 for the years ended December 31, 2003, 2002 and 2001, respectively.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the
United States requires that management make estimates and assumptions that affect the reported amounts
of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial
statements and the reported revenues and expenses during the reporting periods. Actual results could
differ from those estimates.
Impact of Recently Issued Accounting Standards
In June 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations. SFAS No.
143 addresses financial accounting and reporting for obligations associated with the retirement of tangible
long-lived assets and the associated asset retirement costs. It applies to legal obligations associated with
the retirement of long-lived assets that result from the acquisition, construction, development and/or the
normal operation of a long-lived asset, except for certain obligations of lessees. The adoption of this
standard in 2003 did not have any effect on the Company’s financial position, results of operations or
cash flows.
In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of Long-
Lived Assets. SFAS No. 144 addresses financial accounting and reporting for the impairment or disposal
of long-lived assets. The adoption of this standard in 2002 did not have any effect on the Company’s
financial position, results of operations or cash flows.
In July 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal
Activities. SFAS No. 146 addresses significant issues regarding the recognition, measurement and
reporting of costs that are associated with exit and disposal activities, including restructuring activities
that are currently accounted for pursuant to the guidance set forth in EITF No. 94-3, Liability Recognition
for Certain Employee Termination Benefits and Other Costs to Exit an Activity. SFAS No. 146 revises the
accounting for certain lease termination costs and employee termination benefits, which are generally
recognized in connection with restructuring activities. Adoption of this standard in 2003 did not have any
effect on the Company’s financial position, results of operations or cash flows.
On December 31, 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based Compensation—
Transition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based
Compensation, to provide alternative methods of transition to SFAS No. 123’s fair value method of
accounting for stock-based employee compensation. SFAS No. 148 also amends the disclosure provisions
of SFAS No. 123 and APB Opinion No. 28, Interim Financial Reporting, to require disclosure in the
summary of significant accounting policies of the effect’s of an entity’s accounting policy with respect to
48
stock-based compensation. While the Statement does not amend SFAS No. 123 to require companies to
account for employee stock options using the fair value method, the disclosure provisions of SFAS No.
148 are applicable to all companies with stock-based employee compensation, regardless of whether they
account for that compensation using the fair value method of SFAS No. 123 or the intrinsic value method
of Opinion 25. The Company adopted the disclosure requirement of this standard in 2002.
In January 2003, the FASB issued Interpretation 46 (FIN46), Consolidation of Variable Interest Entities.
In general, a variable interest entity is a corporation, partnership, trust, or any other legal structure used
for business purposes that either (a) does not have equity investors with voting rights or (b) has equity
investors that do not provide sufficient financial resources for the entity to support its activities. FIN 46
requires a variable interest entity to be consolidated by a company if that company is subject to a majority
of the risk of loss from the variable interest entity's activities or entitled to receive a majority of the
entity's residual returns or both. The consolidation requirements of FIN 46 apply immediately to variable
interest entities created after January 31, 2003. The consolidation requirements apply to transactions
entered into prior to February 1, 2003 in the first fiscal year or interim period beginning after June 15,
2003. Certain of the disclosure requirements apply in all financial statements issued after January 31,
2003, regardless of when the variable interest entity was established. The adoption of FIN 46 on July 1,
2003 did not have an impact on our financial statements.
In December 2003, the FASB issued Interpretation 46R (FIN 46R), a revision to FIN 46, Consolidation of
Variable Interest Entities. FIN 46R clarifies some of the provisions of FIN 46 and exempts certain entities
from its requirements. FIN 46R is effective at the end of the first interim period ending after March 15,
2004. Entities that have adopted FIN 46 prior to this effective date can continue to apply the provisions of
FIN 46 until the effective date of FIN 46R. As noted above, CPSI adopted FIN 46 on July 1, 2003 and it
did not have an impact on our financial statements. The early adoption of FIN46R did not have an impact
on our financial statements.
In April 2003, the FASB issued SFAS 149, Amendment of Statement 133 on Derivative Instruments and
Hedging Activities, which amends and clarifies accounting for derivative instruments, including certain
derivative instruments embedded in other contracts, and for hedging activities under SFAS 133. The
statement is effective (with certain exceptions) for contracts entered into or modified after June 30, 2003.
This statement will not have an impact on our financial statements.
In May 2003, the FASB issued SFAS 150, Accounting for Certain Financial Instruments with
Characteristics of both Liabilities and Equity. The statement establishes standards for how an issuer
classifies and measures certain financial instruments with characteristics of both liabilities and equity. It
requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in
some circumstances). It is effective for financial instruments entered into or modified after May 31, 2003,
and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. This
statement will not have an impact on our financial statements.
4. NET INCOME PER SHARE
Pro forma net income per share consists of the Company’s historical net income as an S corporation,
adjusted for additional income taxes that would have been recorded had the Company operated as a C
corporation for the entire period presented. The Company presents both basic and diluted earnings per
share (EPS) amounts. Basic EPS is calculated by dividing net income by the weighted average number of
common shares outstanding during the period presented. Diluted EPS amounts are based upon the
weighted average number of common and common equivalent shares outstanding during the period
presented. The difference between basic and diluted EPS is solely attributable to stock options. The
Company uses the treasury stock method to calculate the impact of outstanding stock options. For the
years ended December 31, 2003 and 2002, these dilutive shares were 48,523 and 37,327, respectively.
49
Since the Company’s first award under its’ stock compensation plan was in 2002, there were no dilutive
shares for the year ended December 31, 2001.
5. INCOME TAXES
The financial statements of the Company do not include a provision for income taxes through May 20,
2002 because the taxable income of the Company was included in the income tax returns of the
shareholders under the S corporation election through that date. Upon completion of the IPO, the
Company’s S corporation status was terminated, and the Company became subject to federal and state
income taxes. Upon revocation of the S corporation election, the Company recorded a $934,000 credit to
the deferred tax provision. Prior to its termination as an S corporation, the Company declared a
distribution of earned, but undistributed, accumulated S corporation earnings through the date the
Company became a C corporation. A partial distribution in the amount of $12,750,000 was paid on May
28, 2002. An additional distribution of $1,532,510 was made during the fourth quarter of 2002. During
2003, a final distribution of $250,000, representing the remaining balance due, was paid to pre-IPO
stockholders.
The Company provides for income taxes using the liability method in accordance with SFAS No. 109,
Accounting for Income Taxes. Deferred income taxes arise from the temporary differences in the
recognition of income and expenses for tax purposes. Deferred tax assets and liabilities are comprised of
the following at December 31, 2003 and 2002:
Deferred tax assets:
Accounts receivable
Sales, income and use tax receivables
Sales, income and use tax interest
Accrued liabilities
Deferred tax liabilities:
Deferred compensation
2003
2002
$ 328,253
15,149
-
696,037
$ 217,558
74,229
213,986
586,358
1,039,439
1,092,131
(66,266)
(85,661)
Net deferred tax assets
$ 973,173
$ 1,006,470
Significant components of the income tax provision (benefit) for the year ended December 31, 2003 and
2002 are as follows:
Current provision:
Federal
State
Deferred provision:
Federal
State
2003
2002
$ 4,339,486
644,864
$ 2,575,944
401,342
29,793
3,504
(900,526)
(105,944)
Total income tax provision
$ 5,017,647
$ 1,970,816
50
The difference between income taxes at the U. S. federal statutory income tax rate of 35% and those
reported in the statement of income for the years ended December 31, 2003 and 2002 are as follows:
Income taxes at U. S. Federal statutory rate
State income tax, net of federal tax effect
Impact of graduated tax rates
S corporation
Change in tax status
Other
2003
2002
$ 4,509,217
427,923
(100,000)
-
-
180,507
$ 4,417,213
259,869
(100,000)
(1,657,622)
(934,262)
(14,382)
$ 5,017,647
$ 1,970,816
6. DEFERRED COMPENSATION
On May 17, 2002, Kenny Muscat, one of the Company’s directors and a principal stockholder sold
66,667 shares of common stock to J. Boyd Douglas, Jr., one of the Company’s directors and its Chief
Operating Officer (COO), for a price of $13.20 per share. The share price was determined by an
independent valuation of the fair market value of the shares. A promissory note was delivered for the
entire purchase price. The promissory note bears interest at the applicable rate for federal income tax
purposes, and the entire principal balance is due five years after the date of the stock sale. As a part of the
same transaction, Mr. Muscat also transferred to Mr. Douglas 19,333 shares of common stock for $1.00.
These shares are subject to a mandatory transfer obligation under which Mr. Douglas will be required to
transfer the shares back to Mr. Muscat in the event Mr. Douglas’ employment with the Company
terminates for certain reasons prior to the fifth anniversary of the transaction date. The mandatory transfer
obligation will lapse as to 20% of the shares on each anniversary of the transaction date over the five year
restriction period.
As a result of this transaction, the Company recorded deferred compensation expense of $255,196,
representing the excess of the fair market value of the 19,333 shares transferred by Mr. Muscat to Mr.
Douglas. The Company is amortizing the deferred compensation expense over 20 fiscal quarters,
recognizing pre-tax compensation expense of $12,760 per quarter.
7. STOCK OPTION PLAN
Under the 2002 Stock Option Plan, the Company has authorized the issuance of equity-based awards for
up to 1,165,333 shares of common stock to provide additional incentive to employees and officers.
Pursuant to the plan, the Company can grant either incentive or non-qualified stock options. Options to
purchase common stock under the 2002 Stock Option Plan have been granted to Company employees
with an exercise price equal to the fair market value of the underlying shares on the date of grant.
Stock options granted under the 2002 Stock Option Plan to executive officers of the Company become
vested as to all of the shares covered by such grant on the fifth anniversary of the grant date and expire on
the seventh anniversary of the grant date. Stock options granted under the 2002 Stock Option Plan to
employees other than executive officers become vested as to 50% of the shares covered by the option
grant on the third anniversary of the grant date and as to 100% of such shares on the fifth anniversary of
the grant date, and such options expire on the seventh anniversary of the grant date.
Under the methodology of SFAS No. 123, the fair value of the Company’s stock options was estimated at
the date of grant using the Black-Scholes option pricing model. The multiple option approach was used,
51
with assumptions for expected option life of 5 years and 44% expected volatility for the market price of
the Company’s stock in 2002. An estimated dividend yield of 3% was used. The risk-free rate of return
was determined to be 2.79% in 2002.
The Black-Scholes option valuation model was developed for use in estimating the fair value of traded
options which have no vesting restrictions and are fully transferable. In addition, option valuation models
require the input of highly subjective assumptions, including expected stock price volatility. Because the
Company’s employee stock options have characteristics significantly different from those of traded
options, and because subjectivity of assumptions can materially affect estimate of fair value, the
Company believes the Black-Scholes model does not necessarily provide a reliable single measure of the
fair value of its employee stock options.
The weighted average grant date fair value of options granted to employees under the 2002 Stock Option
Plan during 2002 was $5.30. During 2002, options were granted under the plan at exercise prices equal to
the market value of the Company’s stock on the date of grant.
A summary of stock option activity under the plan is as follows:
2003
Exercise
2002
Exercise
Shares
Price
Shares
Price
Beginning of year
444,998
$ –
–
$ –
Granted
Exercised
Forfeited
–
(1,849)
(18,390)
–
16.50
16.50
466,133
–
(21,135)
16.50
–
16.50
End of year
424,759
$ 16.50
444,998
$ 16.50
Exercisable
312
$ 16.50
–
$ –
Shares available for future grants under
the plan as of December 31, 2003
738,725
720,335
Weighted-average grant date fair value
$ 5.30
$ 5.30
Weighted-average remaining contractual life
5.5 years
6.5 years
8. CONCENTRATION OF CREDIT RISK
Financial instruments, which potentially subject the Company to concentration of credit risk, consist
principally of temporary cash investments and trade receivables. The Company places its temporary cash
investments with credit-worthy, high-quality financial institutions.
The Company’s customer base is concentrated in the healthcare industry. Customers are located
throughout the United States. The Company requires no collateral or other security to support customer
52
receivables. An allowance for doubtful accounts has been established for potential credit losses based on
historical collection experience.
9. FAIR VALUES OF FINANCIAL INSTRUMENTS
Cash, cash equivalents, accounts receivable, accounts payable and accrued liabilities are reflected in the
accompanying financial statements at cost, which approximates fair value because of the short-term
maturity of these instruments. Based on the borrowing rates currently available to the Company for bank
loans with similar terms and average maturities, at December 31, 2003 and 2002 the fair values of the
note payable and financing receivables approximate book value.
10. FINANCING RECEIVABLES
The Company leases its information and patient care systems to certain healthcare providers under sales-
type leases expiring in various years through 2007. These receivables typically have terms from 2 to 5
years, bear interest at various rates, and are usually collateralized by a security interest in the underlying
assets. Since the Company has a history of successfully collecting all amounts due under the original
payment terms of these extended payment arrangements without making any concessions to its customers,
the Company satisfies the requirement of SOP 97-2 for revenue recognition. The Company’s history with
these types of extended payment term arrangements supports management’s assertion that revenues are
fixed and determinable and probable of collection.
The components of these lease receivables were as follows on December 31:
Total minimum lease payments receivable
$ 1,690,917
$ 1,637,908
2003
2002
Less unearned income
Lease receivables
Less current portion
Amounts due after one year
(232,867)
(222,649)
1,458,050
1,415,259
(665,947)
(574,656)
$ 792,103
$ 840,603
Future minimum lease payments to be received at December 31, 2003 are as follows:
2004
2005
2006
2007
2008
Total minimum lease payments to be received
Less unearned income
Net leases receivable
53
$ 751,773
443,896
294,876
132,666
67,706
1,690,917
(232,867)
$ 1,458,050
The Company has also sold information and patient care systems to certain healthcare providers under
extended payment terms. These receivables, included in current portion of financing receivables,
typically have terms from 3 to 12 months and are collateralized by a security interest in the underlying
assets. Total amounts receivable under these arrangements at December 31, 2003 and 2002 were
$448,595 (of which $1,768 is included as a long-term asset) and $766,391, respectively.
11. BENEFIT PLANS
In January 1994, the Company adopted the Computer Programs & System, Inc. 401(k) Retirement Plan
that covers all eligible employees of the Company who have completed one year of service. The plan
allows eligible employees to contribute up to 15% of their pre-tax earnings up to the statutory limit
prescribed by the Internal Revenue Service. The Company matches the first $1,000 contribution per
participant plus a discretionary amount determined by the Company. The Company contributed
approximately $935,000, $816,000 and $739,000 to the plan for the years ended December 31, 2003,
2002 and 2001, respectively.
The Company provides certain health and medical benefits to eligible employees, their spouses and
dependents pursuant to a benefit plan funded by the Company. Each participating employee contributes to
the Company's costs associated with such benefit plan. The Company's obligation to fund this benefit plan
and pay for these benefits is limited through the Company's purchase of an insurance policy from a third-
party insurer. The amount established as a reserve is intended to recognize the Company's estimated
obligations with respect to its payment of claims and claims incurred but not yet reported under the
benefit plan. Management believes that the recorded liability for medical self-insurance at December 31,
2003 and 2002 is adequate to cover the losses and claims incurred, but these reserves are necessarily
based on estimates and the amount ultimately paid may be more or less than such estimates.
12. OPERATING LEASES
The Company leases certain real property, all of which is owned by entities that are owned by one or
more stockholders of the Company. The lease agreements have terms of ten years and expire on or before
June 2013. For the second five years of the leases, the rental may be adjusted with consent of the landlord
and the Company. If mutual consent cannot be obtained, the rental for the second five years will remain
the same as the first five years. For the years ended December 31, 2003, 2002 and 2001, total rent
expense paid to related parties was approximately $1,325,000, $1,112,000 and $958,000, respectively.
The future minimum lease payments payable under operating leases subsequent to December 31, 2003 are
as follows:
2004
2005
2006
2007
2008
Thereafter
$ 1,365,275
1,365,275
1,365,275
1,365,275
1,365,275
4,605,150
$ 11,431,525
54
13. SUBSEQUENT EVENT
On February 3, 2004, the Company announced a dividend for the first quarter of 2004 in the amount of
$0.12 per share.
14. QUARTERLY FINANCIAL STATEMENTS (UNAUDITED)
The following table presents a summary of our results of operations for our eight most recent quarters
ended December 31, 2003. The information for each of these quarters is unaudited and has been prepared
on a basis consistent with the audited financial statements. This information includes all adjustments,
consisting only of normal recurring adjustments, we consider necessary for fair presentation of this
information when read in conjunction with the audited financial statements and related notes. Pro forma
net income and pro forma net income per share data included in this table has been adjusted to include pro
forma corporate income tax provisions as if we had been a C corporation during all of the quarterly
periods. Our operating results have varied on a quarterly basis and may fluctuate significantly in the
future.
Year Ended December 31, 2003
Sales revenues
Gross profit
Operating income
Net income
Net income per share
Basic
Diluted
Weighted average shares
outstanding
Basic
Diluted
Year Ended December 31, 2002
Sales revenues
Gross profit
Operating income
Net income
Net income per share
Basic
Diluted
Pro forma net income
Pro forma net income per share
Basic
Diluted
Weighted average shares
outstanding
Basic
Diluted
1st Quarter 2nd Quarter(1)
3rd Quarter
4th Quarter
(in thousands except for share and per share data)
$ 20,075
8,037
3,224
2,071
$ 19,908
8,320
3,308
2,112
$ 19,591
7,319
2,278
1,461
$ 21,729
9,223
3,735
2,222
0.20
0.20
0.20
0.20
0.14
0.14
0.21
0.21
10,488,000
10,569,223
10,488,000
10,543,577
10,488,000
10,524,832
10,488,181
10,510,879
$ 16,921
7,019
2,799
2,872
$ 17,511
7,199
2,763
3,316
$ 18,897
7,905
3,041
2,077
$ 20,416
8,696
3,466
2,385
0.31
0.31
1,790
0.19
0.19
0.34
0.34
1,792
0.18
0.18
0.20
0.20
2,077
0.20
0.20
0.23
0.23
2,385
0.23
0.23
9,288,000
9,288,000
9,815,473
9,829,027
10,488,000
10,589,226
10,488,000
10,563,331
The 2nd Quarter 2002 information was restated to record a $934,000 tax benefit arising from the Company’s
(1)
change in tax status that occurred on May 21, 2002, the date of the IPO.
55
SCHEDULE II
COMPUTER PROGRAMS AND SYSTEMS, INC.
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
(1)
Additions
charged to
cost and
expenses
Balance at
beginning of
period
(2)
Deductions
Balance at end
of period
2001
2002
2003
$ 479,000
532,000
768,000
$ 225,000
818,000
257,000
$ 172,000
582,000
121,000
$ 532,000
768,000
904,000
Description
Allowance for doubtful accounts
deducted from accounts
receivable in the balance sheet
(1) Adjustments to allowance for change in
estimates.
(2) Uncollectible accounts written off, net of
recoveries.
ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 9A.
CONTROLS AND PROCEDURES.
Our management, under the supervision and with the participation of our Chief Executive Officer
and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of the
end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and
Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in
timely alerting them to material information relating to the Company that is required to be included in our
periodic Securities and Exchange Commission filings.
There have not been any changes in the Company’s internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) during the fourth quarter of 2003 that have
materially affected, or are reasonably likely to materially affect, the Company’s internal control over
financial reporting.
56
PART III
ITEM 10.
DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
We have adopted a Code of Business Conduct and Ethics applicable to all of our directors,
officers (including our Chief Executive Officer and senior financial officers) and employees. We have
also adopted a separate code of ethics with additional guidelines and responsibilities applicable to our
Chief Executive Officer and senior financial officers, known as the Code of Ethics for CEO and Senior
Financial Officers. Copies of the Code of Business Conduct and Ethics and the Code of Ethics for CEO
and Senior Financial Officers are filed as exhibits to this Annual Report on Form 10-K.
Other information required by this Item regarding Executive Officers is included in Part I of this
Form 10-K under the caption "Executive Officers" in accordance with Instruction 3 of the Instructions to
Paragraph (b) of Item 401 of Regulation S-K.
Other information required by this Item is incorporated by reference pursuant to General
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A.
ITEM 11.
EXECUTIVE COMPENSATION
The information required by this Item is incorporated by reference pursuant to General
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A.
ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Certain of the information required by this Item is incorporated by reference pursuant to General
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A.
The following table summaries the securities that have been authorized for issuance under our
2002 Stock Option Plan, which is described in Note 7 of the Notes to the Financial Statements.
Equity Compensation Plan Information
Number of securities
to be issued
upon exercise of
outstanding options,
warrants and rights
(a)
Weighted-average
exercise price of
outstanding options,
warrants and rights
(b)
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
(c)
424,759
$16.50
738,725
-0-
424,759
N/A
-0-
738,725
57
Plan Category
Equity compensation
plans approved by
stockholders
Equity compensation
plans not approved
by stockholders
Total
ITEM 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The information required by this Item is incorporated by reference pursuant to General
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A.
ITEM 14.
PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this Item is incorporated by reference pursuant to General
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A.
58
ITEM 15.
EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON
FORM 8-K.
PART IV
(a)(1) and (2) and (d) - Financial Statements and Financial Statement Schedules.
Financial Statements: The Financial Statements and related Financial Statements
Schedule of CPSI are included herein in Part II, Item 8.
(b)
Reports on Form 8-K.
On October 22, 2003 a report on Form 8-K was furnished to the SEC pursuant to
Item 12 on Form 8-K.
(c)
Exhibits.
The exhibits listed on the Exhibit Index on page 65 of this Form 10-K are filed
herewith or are incorporated herein by reference.
59
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized, on this the 12th day of March, 2004.
COMPUTER PROGRAMS AND SYSTEMS, INC.
By:
/s/ David A. Dye
David A. Dye
President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed
below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Name
Title
Date
/s/ John Morrissey
John Morrissey
/s/ David A. Dye
David A. Dye
/s/ J. Boyd Douglas
J. Boyd Douglas
/s/ M. Stephen Walker
M. Stephen Walker
/s/ Darrell G. West
Darrell G. West
/s/ Dennis P. Wilkins
Dennis P. Wilkins
/s/ M. Kenny Muscat
M. Kenny Muscat
/s/ Ernest F. Ladd, III
Ernest F. Ladd, III
/s/ W. Austin Mulherin, III
W. Austin Mulherin, III
/s/ William R. Seifert, II
William R. Seifert, II
Chairman of the Board and
Director
President, Chief Executive Officer
and Director (principal executive
officer)
March 9, 2003
March 12, 2003
Executive Vice President,
Chief Operating Officer and Director
March 12, 2003
Vice President - Finance and
Chief Financial Officer
March 12, 2003
Controller (principal accounting
officer)
March 12, 2003
Director
Director
Director
Director
Director
March 9, 2003
March 11, 2003
March 11, 2003
March 10, 2003
March 9, 2003
Exhibit
Number
Description
Exhibit Index
3.1
3.2
10.1
Certificate of Incorporation (filed as Exhibit 3.4 to CPSI’s Registration Statement on
Form S-1 (Registration No. 333-84726) and incorporated herein by reference)
Bylaws (filed as Exhibit 3.6 to CPSI’s Registration Statement on Form S-1
(Registration No. 333-84726) and incorporated herein by reference)
Real Property Lease, dated April 1, 2002, between CPSI and CP Investments, Inc. (filed
as Exhibit 10.1 to CPSI’s Registration Statement on Form S-1 (Registration
No. 333-84726) and incorporated herein by reference)
10.2
Real Property Lease dated April 1, 2002, between CPSI and DJK, LLC (filed as Exhibit
10.2 to CPSI’s Registration Statement on Form S-1 (Registration No. 333-84726) and
incorporated herein by reference)
10.3
10.4
10. 5
10.6
10.7
10.8
10.9
10.10
2002 Stock Option Plan (filed as Exhibit 10.3 to CPSI’s Registration Statement on Form
S-1 (Registration No. 333-84726) and incorporated herein by reference)
Form of Non-Qualified Stock Option Agreement for executive officers (filed as Exhibit
10.4 to CPSI’s Registration Statement on Form S-1 (Registration No. 333-84726) and
incorporated herein by reference)
Agreement, dated July 1, 1999, between CPSI, AmSouth Bank and certain shareholders
and officers of CPSI (filed as Exhibit 10.5 to CPSI’s Registration Statement on Form S-1
(Registration No. 333-84726) and incorporated herein by reference)
Agreement, dated May 18, 2001, between CPSI, AmSouth Bank and certain shareholders
and officers of CPSI (filed as Exhibit 10.6 to CPSI’s Registration Statement on Form S-1
(Registration No. 333-84726) and incorporated herein by reference)
Release and Termination Agreement, dated April 26, 2002, between CPSI, AmSouth
Bank and certain shareholders and officers of CPSI (filed as Exhibit 10.7 to CPSI’s
Registration Statement on Form S-1 (Registration No. 333-84726) and incorporated
herein by reference)
Release and Termination Agreement, dated April 26, 2002, between CPSI, AmSouth
Bank, Dennis P. Wilkins and certain officers of CPSI (filed as Exhibit 10.8 to CPSI’s
Registration Statement on Form S-1 (Registration No. 333-84726) and incorporated
herein by reference)
Form of Indemnity Agreement entered into by CPSI and each of its non-employee
directors (filed as Exhibit 10.1 to CPSI’s Quarterly Report on Form 10-Q for the period
ended September 30, 2002 and incorporated herein by reference)
Real Property Lease, dated October 1, 2002, between CPSI and CP Investments, Inc.
(filed as Exhibit 10.10 to CPSI’s Annual Report on Form 10-K for the period ended
December 31, 2002 and incorporated herein by reference)
10.11
Real Property Lease, dated November 1, 2002, between CPSI and CP Investments, Inc.
(filed as Exhibit 10.11 to CPSI’s Annual Report on Form 10-K for the period ended
December 31, 2002 and incorporated herein by reference)
10.12
Real Property Lease, dated June 16, 2003, between CPSI and CP Investments, Inc.
14.1
14.2
23.1
31.1
31.2
32.1
32.2
Code of Business Conduct and Ethics
Code of Ethics for CEO and Senior Financial Officers
Consent of Ernst & Young LLP, Independent Auditors
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Directors and Officers
Board of Directors
David A. Dye
President and Chief Executive Officer
Computer Programs and Systems, Inc.
Ernest F. Ladd, III
Retired Executive Vice President and
M. Kenny Muscat
Retired Executive Vice President and
Chief Financial Officer
Dravo Corporation
Chief Operating Officer
Computer Programs and Systems, Inc.
J. Boyd Douglas, Jr.
Executive Vice President and
Chief Operating Officer
John W. Morrissey
Retired Vice President, Sales
Computer Programs and Systems, Inc.
and Marketing
Computer Programs and Systems, Inc.
W. Austin Mulherin, III
Attorney
Frazer, Greene, Upchurch &
Baker, LLC
William R. Seifert, II
Executive Vice President
AmSouth Bank
Dennis P. Wilkins
Retired President and
Chief Executive Officer
Computer Programs and Systems, Inc.
Officers
David A. Dye
President and Chief Executive Officer
J. Boyd Douglas, Jr.
Executive Vice President and
Chief Operating Officer
M. Stephen Walker
Vice President of Finance and
Chief Financial Officer
Corporate Data
Independent Accountants
Ernst & Young LLP
1901 Sixth Avenue North
Suite 1900, AmSouth/Harbert Plaza
Birmingham, AL 35203-2618
Transfer Agent
Wachovia Bank, N.A.
Equity Services Group
1525 West W. T Harris Blvd., 3C3
Charlotte, NC 28262-1153
Legal Counsel
Maynard, Cooper & Gale, P.C.
1901 Sixth Avenue North
Suite 2400, AmSouth/Harbert Plaza
Birmingham, AL 35203-2618
Corporate Headquarters
Computer Programs and Systems, Inc.
6600 Wall Street
Mobile, AL 36695
(251) 639-8100
www.cpsinet.com
Common Stock
Computer Programs and Systems,
Inc.’s common stock is traded on
The NASDAQ Stock Market’s
National Market under the symbol
CPSI.
C
CPSI
6600 Wall Street
Mobile, AL 36695